Sign In

Login

Password

Forgot Password ? Sign Up

Vakcína proti covidu-19 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vakcína proti covidu-19" in Czech language version.

refsWebsite
Global rank Czech rank
75doi.org
2nd place
4th place
59nih.gov
4th place
8th place
44web.archive.org
1st place
1st place
41worldcat.org
5th place
3rd place
41reuters.com
49th place
92nd place
20clinicaltrials.gov
5,225th place
2,661st place
16novinky.cz
1,270th place
5th place
15europa.eu
68th place
38th place
12seznamzpravy.cz
4,711th place
29th place
12idnes.cz
442nd place
2nd place
11who.int
195th place
168th place
10irozhlas.cz
3,217th place
16th place
9elsevier.com
610th place
203rd place
9thelancet.com
2,393rd place
974th place
9medicalxpress.com
8,255th place
77th place
8nytimes.com
7th place
43rd place
8nature.com
234th place
72nd place
8gov.uk
432nd place
717th place
7washingtonpost.com
34th place
133rd place
7bbc.com
20th place
48th place
6cepi.net
low place
low place
6sputnikvaccine.com
low place
low place
5ceskatelevize.cz
1,281st place
6th place
4cdc.gov
218th place
304th place
4aktualne.cz
2,459th place
13th place
4bloomberg.com
99th place
267th place
4aa.com.tr
754th place
3,840th place
4xinhuanet.com
309th place
1,335th place
4sukl.cz
low place
373rd place
4cnn.com
28th place
74th place
4mzcr.cz
low place
573rd place
3harvard.edu
18th place
99th place
3gavi.org
low place
low place
3go.com
48th place
247th place
3gatesnotes.com
low place
low place
3fda.gov
447th place
753rd place
3ceskenoviny.cz
5,151st place
40th place
3nejm.org
2,374th place
1,252nd place
3africanews.com
3,550th place
9,601st place
3echo24.cz
low place
87th place
3canada.ca
1,712th place
4,416th place
3bmj.com
1,226th place
800th place
3rozhlas.cz
1,783rd place
9th place
2semanticscholar.org
11th place
313th place
2theguardian.com
12th place
39th place
2lidovky.cz
2,549th place
14th place
2theglobeandmail.com
293rd place
1,962nd place
2yahoo.com
38th place
190th place
2businessinsider.com
140th place
332nd place
2theconversation.com
928th place
1,272nd place
2scmp.com
362nd place
1,155th place
2shinyapps.io
low place
low place
2statnews.com
8,771st place
9,528th place
2oup.com
485th place
155th place
2clinicaltrialsregister.eu
low place
low place
2curevac.com
low place
low place
2thestar.com
336th place
1,354th place
2pfizer.com
low place
low place
2euronews.com
612th place
1,860th place
2aljazeera.com
268th place
476th place
2straitstimes.com
543rd place
2,127th place
2msn.com
117th place
405th place
2france24.com
481st place
903rd place
2rferl.org
737th place
379th place
2apnews.com
129th place
250th place
2moz.gov.ua
low place
low place
2tga.gov.au
3,984th place
low place
2laegemiddelstyrelsen.dk
low place
low place
2lyfjastofnun.is
low place
low place
2nikkei.com
211th place
3,194th place
2legemiddelverket.no
low place
low place
2gulfnews.com
765th place
2,794th place
2vnexpress.net
839th place
6,367th place
2trust.org
9,070th place
low place
2thestar.com.my
574th place
6,850th place
2tass.com
1,763rd place
2,154th place
2thehindu.com
52nd place
2,627th place
2royanews.tv
low place
low place
2nova.cz
5,821st place
36th place
2iprima.cz
8,156th place
57th place
2cnbc.com
220th place
626th place
1praha.eu
low place
228th place
1bworldonline.com
5,578th place
low place
1buzzfeednews.com
1,368th place
7,411th place
1globalcommissionforpostpandemicpolicy.org
low place
low place
1un.org
97th place
111th place
1gatesfoundation.org
low place
low place
1glopid-r.org
low place
low place
1nhs.uk
1,989th place
1,996th place
1scientificamerican.com
896th place
558th place
1bio.org
low place
low place
1asm.org
3,555th place
1,232nd place
1acs.org
1,248th place
807th place
1npr.org
92nd place
367th place
1isrctn.com
low place
low place
1fortune.com
433rd place
766th place
1wiley.com
222nd place
83rd place
1ina-registry.org
low place
low place
1chictr.org.cn
low place
low place
1farsnews.ir
1,083rd place
low place
1vaccine-safety-training.org
low place
low place
1tandfonline.com
507th place
215th place
1ctri.nic.in
low place
low place
1ivi.int
low place
low place
1forbes.com
54th place
90th place
1brusselstimes.com
8,796th place
5,285th place
1hln.be
1,292nd place
7,189th place
1texastribune.org
3,618th place
low place
1ox.ac.uk
613th place
692nd place
1sciencemag.org
857th place
315th place
1janssen.com
low place
low place
1politico.com
312th place
942nd place
1dw.com
204th place
352nd place
1chicagotribune.com
95th place
633rd place
1investicniweb.cz
low place
1,771st place
1indiatoday.in
94th place
5,754th place
1uq.edu.au
3,558th place
low place
1phys.org
1,283rd place
26th place
1sanofi.com
low place
low place
1winfried-stoecker.de
low place
low place
1euractiv.com
3,286th place
1,702nd place
1denik.cz
2,040th place
11th place
1thesun.co.uk
1,600th place
1,416th place
1medrxiv.org
low place
low place
1science.org
1,160th place
346th place
1seenews.com
low place
8,785th place
1govern.ad
low place
low place
1lanacion.com.ar
291st place
2,976th place
1controlsanitario.gob.ec
low place
low place
1cnnphilippines.com
2,993rd place
low place
1jpost.com
544th place
678th place
1ticotimes.net
low place
low place
1arab.news
6,427th place
low place
1trackvaccines.org
low place
low place
1gouv.mc
4,306th place
6,456th place
1health.govt.nz
low place
low place
1emirateswoman.com
low place
low place
1newsd.in
low place
low place
1gov.vc
low place
low place
1admin.ch
279th place
431st place
1swissmedicinfo.ch
low place
low place
1ncronline.org
4,690th place
low place
1vaticannews.va
3,298th place
958th place
1globo.com
62nd place
1,703rd place
1alarabiya.net
598th place
3,138th place
1balkaninsight.com
2,699th place
2,055th place
1srbija.gov.rs
low place
low place
1modernatx.com
low place
low place
1swissmedic.ch
low place
low place
1ssrn.com
703rd place
1,110th place
1saudigazette.com.sa
5,190th place
low place
1thedailystar.net
593rd place
4,133rd place
1efe.com
2,412th place
low place
1caricom.org
low place
low place
1paho.org
8,358th place
low place
1bignewsnetwork.com
low place
low place
1gob.mx
3,255th place
low place
1pattayamail.com
low place
low place
1channelnewsasia.com
1,127th place
low place
1abc.net.au
139th place
475th place
1yna.co.kr
981st place
6,800th place
1aps.dz
4,743rd place
low place
1minsalud.gob.bo
low place
low place
1pharmiweb.com
low place
low place
1neweurope.eu
low place
low place
1thejakartapost.com
1,142nd place
3,872nd place
1urdupoint.com
low place
low place
1wsoctv.com
low place
low place
1dawn.com
354th place
3,962nd place
1rdif.ru
low place
low place
1unionesarda.it
9,671st place
low place
1khaleejtimes.com
1,924th place
low place
1n1info.com
4,502nd place
3,985th place
1indiablooms.com
low place
low place
1news24.com
1,309th place
2,481st place
1thenigerianvoice.com
low place
low place
1themoscowtimes.com
1,388th place
923rd place
1barrons.com
2,737th place
low place
1uol.com.br
74th place
3,781st place
1tempo.co
1,326th place
7,066th place
1financialtribune.com
low place
low place
1khmertimeskh.com
5,543rd place
low place
1nationalpost.com
818th place
2,583rd place
1yabiladi.com
6,646th place
low place
1kathmandupost.com
3,868th place
7,356th place
1arabianbusiness.com
2,557th place
low place
1statehouse.gov.sc
low place
low place
1thenationalnews.com
1,682nd place
2,610th place
1businesstoday.in
1,332nd place
low place
1irna.ir
643rd place
low place
1hindustantimes.com
71st place
2,675th place
1rospotrebnadzor.ru
low place
low place
1thepharmaletter.com
low place
low place
1tdh.gov.tm
low place
low place
1weforum.org
1,771st place
3,473rd place
1cbc.ca
115th place
337th place
1covid.is
low place
low place
1vg.no
1,177th place
3,270th place
1valneva.com
low place
low place
1medigenvac.com
low place
low place
1faz.net
240th place
404th place
1reflex.cz
9,262nd place
60th place
1precisionvaccinations.com
low place
low place
1jamanetwork.com
2,650th place
1,128th place
1sciencedirect.com
149th place
80th place
1thegatewaypundit.com
low place
low place
1statista.com
776th place
487th place
1japantimes.co.jp
389th place
812th place
1twitter.com
23rd place
106th place
1coe.int
772nd place
707th place
1boston.com
310th place
1,444th place

aa.com.tr

  • Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine [online]. [cit. 2021-01-06]. Dostupné online. (anglicky) 
  • ALIYEV, Jeyhun. Azerbaijan kicks off COVID-19 vaccination. aa.com.tr [online]. 2021-01-19 [cit. 2021-02-25]. Dostupné online. (anglicky) 
  • ALIYEV, Jeyhun. Colombia approves emergency use of CoronaVac vaccine [online]. Anadolu Agency [cit. 2021-02-07]. Dostupné online. 
  • Turkey to begin COVID-19 vaccine jabs by this weekend. Anadolu. 2021-01-11. Dostupné online [cit. 2021-01-11]. 

abc.net.au

  • AstraZeneca coronavirus vaccine approved for use in Australia by TGA. ABC News. 16 February 2021. Dostupné online [cit. 16 February 2021]. 

acs.org

cen.acs.org

admin.ch

bag.admin.ch

africanews.com

  • AFRICANEWS. Mauritius begins vaccinating frontline health workers against covid-19 [online]. 2021-01-26CET18:11:44+01:00 [cit. 2021-02-24]. Dostupné online. (anglicky) 
  • Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine. africanews.. 31 December 2020. Dostupné online. (anglicky) 
  • ASALA, Kizzi. Senegal Kicks Off COVID-19 Vaccination Campaign with China’s Sinopharm [online]. Africanews [cit. 2021-02-23]. Dostupné online. (anglicky) 

aktualne.cz

zpravy.aktualne.cz

alarabiya.net

english.alarabiya.net

  • Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use [online]. 10 December 2020 [cit. 2020-12-10]. Dostupné online. 

aljazeera.com

  • Bahrain becomes second country to approve Pfizer COVID-19 vaccine [online]. Al Jazeera [cit. 2020-12-05]. Dostupné online. 
  • India donates 500,000 COVID vaccines to Afghanistan [online]. [cit. 2021-02-24]. Dostupné online. (anglicky) 

apnews.com

  • Singapore approves use of Pfizer's COVID-19 vaccine [online]. 14 December 2020 [cit. 2020-12-15]. Dostupné online. 
  • Sri Lanka approves vaccine amid warnings of virus spread [online]. 2021-01-22 [cit. 2021-01-22]. Dostupné online. 

aps.dz

  • Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine. Algeria Press service. 10 January 2021. Dostupné online. 

arab.news

  • Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine [online]. 13 December 2020 [cit. 2020-12-15]. Dostupné online. 

arabianbusiness.com

  • Bahrain approves China's Sinopharm coronavirus vaccine. arabianbusiness.com [online]. 2020-12-13 [cit. 2021-02-25]. Dostupné online. (anglicky) 

asm.org

journals.asm.org

balkaninsight.com

  • Serbia leads region in expecting COVID-19 vaccines within days. BalkanInsight. 21 December 2020. Dostupné online [cit. 26 December 2020]. 

barrons.com

  • Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use. www.barrons.com. Agence France-Presse (Barron's), 17 February 2021. Dostupné online. 

bbc.com

  • Covax vaccine-sharing scheme delivers first doses to Ghana. BBC News. 2021-02-24. Dostupné online [cit. 2021-02-27]. (anglicky) 
  • FOX, Chris; KELION, Leo. Russian spies 'target coronavirus vaccine'. BBC News. 16 July 2020. Dostupné v archivu pořízeném z originálu dne 11 October 2020. 
  • Johnson & Johnson Covid vaccine: FDA approves single-shot jab, BBC News, 28.2.2021
  • GALLAGHER, James. Moderna: Covid vaccine shows nearly 95% protection. BBC News [online]. 2020-11-16 [cit. 2020-11-20]. Dostupné online. (anglicky) 
  • Covid-19 vaccine: First person receives Pfizer Covid-19 vaccine in UK. BBC News. 2020-12-08. Dostupné online [cit. 2020-12-08]. (anglicky) 
  • Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria. BBC News Pidgin. Dostupné online [cit. 2021-02-24]. 
  • Coronavirus: South Africa rolls out vaccination programme [online]. Feb 17, 2021 [cit. 2021-02-19]. Dostupné online. 

bignewsnetwork.com

  • Iraq approves Sinopharm, AstraZeneca vaccines. bignewsnetwork.com [online]. 2021-01-20 [cit. 2021-02-25]. Dostupné online. (anglicky) 

bio.org

  • Clinical Development Success Rates 2006–2015 [online]. BIO Industry Analysis, June 2016 [cit. 2020-03-23]. Dostupné v archivu pořízeném z originálu dne 12 September 2019. 

bloomberg.com

  • Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges. Bloomberg. 12 December 2020. Dostupné online [cit. 12 December 2020]. 
  • Kenya Approves Sputnik V Vaccine; 10th African Nation to Do So. Bloomberg [online]. [cit. 2021-03-11]. Dostupné online. (anglicky) 
  • CoronaVac’s Overall Efficacy in Brazil Measured at 50.4% [online]. 12 January 2021 [cit. 2021-01-12]. Dostupné online. 
  • China State-Backed Covid Vaccine Has 86 % Efficacy, UAE Says. Bloomberg.com [online]. 2020-12-09. Dostupné online. 

bmj.com

jme.bmj.com

bmj.com

boston.com

  • CHRISTOPHER, Gavin. Boston firefighters union president calls city's vaccine mandate a 'violation' of human rights. www.boston.com [online]. Boston Globe Media, 2021-08-13 [cit. 2023-03-30]. Dostupné online. (anglicky) 

brusselstimes.com

  • European vaccine prices revealed in Belgian Twitter blunder [online]. 18 December 2020. Dostupné online. 

businessinsider.com

  • HAMILTON, Isobel Asher. Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates and one could be ready in as little as 9 months. Business Insider. 2020-05-01. Dostupné v archivu pořízeném z originálu dne 16 May 2020. 
  • BAKER, Sinéad. Pfizer's chairman says it's not clear whether people who are vaccinated can still spread COVID-19. Business Insider [online]. 2020-12-04 [cit. 2020-12-28]. Dostupné online. (anglicky) 

businesstoday.in

  • All Indian COVID-19 vaccines have to be stored at 2-8 degrees Celsius: DBT. www.businesstoday.in [online]. [cit. 2021-01-08]. Dostupné online. 

buzzfeednews.com

  • Vergano D. COVID-19 Vaccines Work Way Better Than We Had Ever Expected. Scientists Are Still Figuring Out Why. [online]. 5 June 2021 [cit. 2021-06-24]. Dostupné online. 

bworldonline.com

  • Padilla TB. No one is safe unless everyone is safe. BusinessWorld. 24 February 2021. Dostupné online [cit. 24 February 2021]. 

canada.ca

covid-vaccine.canada.ca

  • Drug Details. covid-vaccine.canada.ca [online]. [cit. 2021-11-22]. Dostupné online. 
  • Regulatory Decision Summary – Moderna COVID-19 Vaccine – Health Canada [online]. Health Canada, Government of Canada, 23 December 2020 [cit. 2020-12-23]. Dostupné online. 

canada.ca

  • Drug and vaccine authorizations for COVID-19: List of applications received [online]. Health Canada, Government of Canada, 9 December 2020 [cit. 2024-08-15]. Dostupné online. 

caricom.org

today.caricom.org

  • Guyana gets first batch of COVID-19 vaccines; CARICOM Secretariat to get 100 doses [online]. Feb 10, 2021 [cit. 2021-02-19]. Dostupné online. 

cbc.ca

  • Johnson & Johnson COVID-19 vaccine becomes 4th to receive Health Canada approval | CBC News. www.cbc.ca. Canadian Broadcasting Corporation. Dostupné online [cit. 5 March 2021]. (anglicky) 

cdc.gov

  • ACIP COVID-19 Vaccine Recommendations | CDC. www.cdc.gov [online]. 2021-11-19 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • CDC. Understanding Viral Vector COVID-19 Vaccines. Centers for Disease Control and Prevention [online]. 2021-10-18 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • Live Attenuated Influenza Vaccine [LAIV] (The Nasal Spray Flu Vaccine) | CDC. www.cdc.gov [online]. 2021-10-15 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • OLIVER, Sara E.; GARGANO, Julia W.; MARIN, Mona; WALLACE, Megan; CURRAN, Kathryn G.; CHAMBERLAND, Mary; MCCLUNG, Nancy. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020. MMWR. Morbidity and Mortality Weekly Report. December 2020, s. 1653–1656. Dostupné online. DOI 10.15585/mmwr.mm695152e1. PMID 33382675. 

cepi.net

  • COVAX: CEPI's response to COVID-19 [online]. Coalition for Epidemic Preparedness Innovations (CEPI), 2020 [cit. 2020-12-15]. Dostupné online. 
  • New vaccines for a safer world [online]. CEPI, 2020 [cit. 2020-12-15]. Dostupné online. 
  • Our portfolio: partnerships to develop vaccines against COVID-19 [online]. CEPI, 2020 [cit. 2020-12-15]. Dostupné online. 
  • Nick Jackson. Why we need a “portfolio approach” to COVID-19 vaccine development [online]. CEPI, 28 September 2020 [cit. 2020-12-15]. Dostupné online. 
  • CEPI's COVID-19 vaccine portfolio [online]. CEPI, 2020 [cit. 2020-12-15]. Dostupné online. 
  • CEPI and SK bioscience extend collaboration to develop ‘next generation’ COVID-19 vaccine [online]. CEPI, 9 December 2020 [cit. 2020-12-15]. Dostupné online. 

ceskatelevize.cz

ct24.ceskatelevize.cz

ceskenoviny.cz

  • Pfizer a Moderna testují účinnost svých vakcín proti nové mutaci. ceskenoviny.cz [online]. 2020-12-22 [cit. 2020-12-22]. Dostupné online. 
  • EK schválila používání vakcíny firmy Johnson & Johnson v EU. ceskenoviny.cz [online]. 2021-03-11 [cit. 2022-01-10]. Dostupné online. 
  • Očkovací centrum v O2 universum se otevře 11. dubna. ČTK [online]. 2021-03-01 [cit. 2021-03-11]. Dostupné online. 

channelnewsasia.com

  • Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress [online]. [cit. 2021-02-05]. Dostupné online. (anglicky) 

chicagotribune.com

  • BOUFFARD, Karen. Why experts say Moderna COVID-19 vaccine holds advantage over Pfizer’s candidate. chicagotribune.com [online]. 2020-11-17 [cit. 2020-12-28]. Dostupné online. (anglicky) 

chictr.org.cn

  • Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform. www.chictr.org.cn [online]. [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 

clinicaltrials.gov

  • Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Investigating a Vaccine Against COVID-19 - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • A Study of Ad26.COV2.S in Adults (COVID-19) - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-09-16 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-09-16. 
  • A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-09-26 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-09-26. 
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • VALNEVA AUSTRIA GMBH. A Phase I/II Randomized, Two Parts, Dose-Finding Study To Evaluate The Safety, Tolerability and Immunogenicity Of An Inactivated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate (VLA2001), Against Covid-19 In Healthy Subjects. [s.l.]: [s.n.] Dostupné online. Submitted: December 15, 2020. 
  • FEDERAL BUDGETARY RESEARCH INSTITUTION STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY "VECTOR". Simple, Blind, Placebo-controlled, Randomized Study of the Safety, Reactogenicity and Immunogenicity of Vaccine Based on Peptide Antigens for the Prevention of COVID-19 (EpiVacCorona), in Volunteers Aged 18-60 Years (I-II Phase). [s.l.]: [s.n.] Dostupné online. Submitted: August 11, 2020. 
  • THE UNIVERSITY OF QUEENSLAND. A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Dosage-Escalation, Single Centre Study to Evaluate the Safety and Immunogenicity of an Adjuvanted SARS-CoV-2 Sclamp Protein Subunit Vaccine in Healthy Adults Aged 18 to 55 Years Old and Healthy Older Adults, Aged 56 Years and Over. [s.l.]: [s.n.] Dostupné online. Submitted: July 13, 2020. 
  • INOVIO PHARMACEUTICALS. Phase 1 Open-label Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers. [s.l.]: [s.n.] Dostupné online. Submitted: April 3, 2020. 
  • ANGES, INC. A Non-randomized, Open-label, Non-controlled Phase I/II Study to Assess Safety and Immunogenicity of Two Doses of Intramuscular AG0301-COVID19 (1mg/2mg) in Healthy Adults. [s.l.]: [s.n.] Dostupné online. Submitted: July 8, 2020. 
  • GENEXINE, INC. A Phase 1/2a, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Immunogenicity of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Subjects. [s.l.]: [s.n.] Dostupné online. Submitted: June 19, 2020. 
  • CHANG, Lung-Ji. Safety and Immunity Evaluation of A Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine. [s.l.]: [s.n.] Dostupné online. Submitted: March 5, 2020. 
  • SHENZHEN GENO-IMMUNE MEDICAL INSTITUTE. Phase I/II Multicenter Trial of Lentiviral Minigene Vaccine (LV-SMENP) of Covid-19 Coronavirus. [s.l.]: [s.n.] Dostupné online. Submitted: February 17, 2020. 
  • ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IIBR). A Phase I/II Randomized, Multi-Center, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine (IIBR-100) in Adults. [s.l.]: [s.n.] Dostupné online. Submitted: October 26, 2020. 
  • https://clinicaltrials.gov/ct2/show/NCT04283461 - Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)
  • https://clinicaltrials.gov/ct2/show/study/NCT04368728 - Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
  • Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona) [online]. United States National Library of Medicine, 22 September 2020 [cit. 2020-11-16]. Dostupné online. NCT04368988. 
  • https://clinicaltrials.gov/ct2/show/NCT04611802 - A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2

clinicaltrialsregister.eu

cnbc.com

  • SIGALOS, MacKenzie. You can’t sue Pfizer or Moderna if you have severe Covid vaccine side effects. The government likely won't compensate you for damages either. CNBC [online]. 2020-12-17 [cit. 2023-04-11]. Dostupné online. (anglicky) 
  • TAYLOR, Chloe. Are Covid vaccine mandates ethical? Here’s what medical experts think. CNBC [online]. 2021-11-24 [cit. 2023-03-30]. Dostupné online. (anglicky) 

cnn.com

edition.cnn.com

  • REYNOLDS, Emma; HALASZ, Stephanie; PLEITGEN, Frederik; ISAAC, Lindsay. UK becomes first country to authorize Pfizer/BioNTech's Covid-19 vaccine, first shots roll out next week. CNN [online]. 2020-12-03 [cit. 2020-12-28]. Dostupné online. (anglicky) 
  • GAN, Nectar. China approves Sinopharm Covid-19 vaccine, promises free shots for all citizens. CNN [online]. 2020-12-31 [cit. 2021-02-25]. Dostupné online. (anglicky) 

cnn.com

  • HOWARD, Jacqueline. New coronavirus subvariants escape antibodies from vaccination and prior Omicron infection, studies suggest. CNN [online]. 2022-06-22 [cit. 2023-04-08]. Dostupné online. (anglicky) 
  • MARUYAMA, Jessie Yeung,Mayumi. Japan births fall to record low as population crisis deepens. CNN [online]. 2023-03-01 [cit. 2023-04-24]. Dostupné online. (anglicky) 

cnnphilippines.com

  • PH authorizes Pfizer's COVID-19 vaccine for emergency use. cnnphilippines.com. CNN Philippines, 14 January 2021. Dostupné online [cit. 14 January 2021]. 

coe.int

pace.coe.int

controlsanitario.gob.ec

  • Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria [online]. [cit. 2020-12-17]. Dostupné online. (španělsky) 

covid.is

  • An overview of vaccine contracts for Iceland. covid.is [online]. [cit. 2021-03-20]. Dostupné v archivu pořízeném z originálu dne 2021-02-23. 

ctri.nic.in

curevac.com

  • CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60. CureVac [online]. 2021-06-30 [cit. 2021-11-22]. Dostupné online. (anglicky) 
  • CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Suitable for Standard Fridge Temperature Logistics [online]. CureVac, 2020-11-12 [cit. 2021-01-03]. Dostupné online. (anglicky) 

dawn.com

  • Govt okays Russian vaccine for ‘emergency use’. Dawn. 24 January 2021. Dostupné online. 

denik.cz

doi.org

dx.doi.org

  • Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science. December 2020, s. 104. DOI 10.1186/s12929-020-00695-2. PMID 33341119. 
  • Subbarao K. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host & Microbe. July 2021, s. 1111–1123. DOI 10.1016/j.chom.2021.06.016. PMID 34265245. 
  • Mallapaty S, Callaway E, Kozlov M, Ledford H, Pickrell J, Van Noorden R. How COVID vaccines shaped 2021 in eight powerful charts. Nature. December 2021, s. 580–583. DOI 10.1038/d41586-021-03686-x. PMID 34916666. S2CID 245262732. Bibcode 2021Natur.600..580M. 
  • LE, Tung Thanh; CRAMER, Jakob P.; CHEN, Robert; MAYHEW, Stephen. Evolution of the COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 4 September 2020, s. 667–68. ISSN 1474-1776. DOI 10.1038/d41573-020-00151-8. PMID 32887942. S2CID 221503034. 
  • THANH LE, Tung; ANDREADAKIS, Zacharias; KUMAR, Arun; GÓMEZ ROMÁN, Raúl; TOLLEFSEN, Stig; SAVILLE, Melanie; MAYHEW, Stephen. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 9 April 2020, s. 305–06. ISSN 1474-1776. DOI 10.1038/d41573-020-00073-5. PMID 32273591. 
  • Gouglas D, Thanh Le T, Henderson K, Kaloudis A, Danielsen T, Hammersland NC, Robinson JM, Heaton PM, Røttingen JA. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study. Lancet Global Health. December 2018, s. e1386–96. DOI 10.1016/S2214-109X(18)30346-2. PMID 30342925. 
  • DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics. May 2016, s. 20–33. DOI 10.1016/j.jhealeco.2016.01.012. PMID 26928437. 
  • Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK. Ensuring global access to COVID‑19 vaccines. Lancet. May 2020, s. 1405–06. DOI 10.1016/S0140-6736(20)30763-7. PMID 32243778. 
  • Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology. December 2003, s. 567–82. DOI 10.1080/03079450310001621198. PMID 14676007. 
  • Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD, Bellini WJ, Barratt-Boyes S, Gambotto A. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet. December 2003, s. 1895–96. DOI 10.1016/S0140-6736(03)14962-8. PMID 14667748. 
  • Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, AlHajri F, Osterhaus AD, Haagmans BL, Gambotto A. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Vaccine. October 2014, s. 5975–82. DOI 10.1016/j.vaccine.2014.08.058. PMID 25192975. 
  • Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. The Journal of Infectious Diseases. February 2005, s. 507–14. DOI 10.1086/427242. PMID 15655773. 
  • Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. Journal of Virological Methods. September 2005, s. 21–28. DOI 10.1016/j.jviromet.2005.03.021. PMID 15885812. 
  • Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, Vogel L, Hayes N, Sullivan JL, Zaki S, Subbarao K, Ambrosino DM. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. The Journal of Infectious Diseases. March 2006, s. 685–92. DOI 10.1086/500143. PMID 16453264. 
  • Jiang S, Lu L, Du L. Development of SARS vaccines and therapeutics is still needed. Future Virology. January 2013, s. 1–2. DOI 10.2217/fvl.12.126. PMID 32201503. 
  • SHEHATA, Mahmoud M.; GOMAA, Mokhtar R.; ALI, Mohamed A.; KAYALI, Ghazi. Middle East respiratory syndrome coronavirus: a comprehensive review. Frontiers of Medicine. January 2016, s. 120–36. DOI 10.1007/s11684-016-0430-6. PMID 26791756. 
  • Butler D. SARS veterans tackle coronavirus. Nature. October 2012, s. 20. DOI 10.1038/490020a. PMID 23038444. Bibcode 2012Natur.490...20B. 
  • Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K, Reuschel EL, Robb ML, Racine T, Oh MD, Lamarre C, Zaidi FI, Boyer J, Kudchodkar SB, Jeong M, Darden JM, Park YK, Scott PT, Remigio C, Parikh AP, Wise MC, Patel A, Duperret EK, Kim KY, Choi H, White S, Bagarazzi M, May JM, Kane D, Lee H, Kobinger G, Michael NL, Weiner DB, Thomas SJ, Maslow JN. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet. Infectious Diseases. September 2019, s. 1013–22. DOI 10.1016/S1473-3099(19)30266-X. PMID 31351922. 
  • Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS. Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Frontiers in Microbiology. 2019, s. 1781. DOI 10.3389/fmicb.2019.01781. PMID 31428074. 
  • Gates B. Responding to Covid-19: A once-in-a-century pandemic?. The New England Journal of Medicine. February 2020, s. 1677–79. DOI 10.1056/nejmp2003762. PMID 32109012. 
  • Fauci AS, Lane HC, Redfield RR. Covid-19: Navigating the uncharted. The New England Journal of Medicine. March 2020, s. 1268–69. DOI 10.1056/nejme2002387. PMID 32109011. 
  • SIMPSON, Shmona; KAUFMANN, Michael C.; GLOZMAN, Vitaly; CHAKRABARTI, Ajoy. Disease X: accelerating the development of medical countermeasures for the next pandemic. The Lancet. Infectious Diseases. May 2020, s. e108–15. ISSN 1474-4457. DOI 10.1016/S1473-3099(20)30123-7. PMID 32197097. 
  • DIAMOND, Michael S; PIERSON, Theodore C. The challenges of vaccine development against a new virus during a pandemic. Cell Host and Microbe. 13 May 2020, s. 699–703. DOI 10.1016/j.chom.2020.04.021. PMID 32407708. 
  • LE, Tung Thanh; CRAMER, Jakob P.; CHEN, Robert. Evolution of the COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 2020-10, roč. 19, čís. 10, s. 667–668. Dostupné online [cit. 2021-11-22]. ISSN 1474-1776. DOI 10.1038/d41573-020-00151-8. (anglicky) 
  • ARBEITMAN, Claudia R.; ROJAS, Pablo; OJEDA-MAY, Pedro. The SARS-CoV-2 spike protein is vulnerable to moderate electric fields. Nature Communications. 2021-12, roč. 12, čís. 1, s. 5407. Dostupné online [cit. 2021-11-22]. ISSN 2041-1723. DOI 10.1038/s41467-021-25478-7. PMID 34518528. (anglicky) 
  • GRIFONI, Alba; WEISKOPF, Daniela; RAMIREZ, Sydney I. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020-06, roč. 181, čís. 7, s. 1489–1501.e15. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.cell.2020.05.015. PMID 32473127. (anglicky) 
  • DUTTA, Noton K.; MAZUMDAR, Kaushiki; GORDY, James T. The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development. Journal of Virology. 2020-06-16, roč. 94, čís. 13. Dostupné online [cit. 2021-11-22]. ISSN 0022-538X. DOI 10.1128/JVI.00647-20. PMID 32546606. (anglicky) 
  • NIKOLAIDIS, Marios; MARKOULATOS, Panayotis; VAN DE PEER, Yves. The Neighborhood of the Spike Gene Is a Hotspot for Modular Intertypic Homologous and Nonhomologous Recombination in Coronavirus Genomes. Molecular Biology and Evolution. 2021-10-12, s. msab292. Dostupné online [cit. 2021-11-22]. ISSN 0737-4038. DOI 10.1093/molbev/msab292. PMID 34638137. (anglicky) 
  • THANH LE, Tung; ANDREADAKIS, Zacharias; KUMAR, Arun. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 2020-05, roč. 19, čís. 5, s. 305–306. Dostupné online [cit. 2021-11-22]. ISSN 1474-1776. DOI 10.1038/d41573-020-00073-5. (anglicky) 
  • DIAMOND, Michael S.; PIERSON, Theodore C. The Challenges of Vaccine Development against a New Virus during a Pandemic. Cell Host & Microbe. 2020-05, roč. 27, čís. 5, s. 699–703. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.chom.2020.04.021. PMID 32407708. (anglicky) 
  • KRAMMER, Florian. SARS-CoV-2 vaccines in development. Nature. 2020-10-22, roč. 586, čís. 7830, s. 516–527. Dostupné online [cit. 2021-11-22]. ISSN 0028-0836. DOI 10.1038/s41586-020-2798-3. (anglicky) 
  • PARK, Kyung Soo; SUN, Xiaoqi; AIKINS, Marisa E. Non-viral COVID-19 vaccine delivery systems. Advanced Drug Delivery Reviews. 2021-02, roč. 169, s. 137–151. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.addr.2020.12.008. PMID 33340620. (anglicky) 
  • KOWALSKI, Piotr S.; RUDRA, Arnab; MIAO, Lei. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Molecular Therapy. 2019-04, roč. 27, čís. 4, s. 710–728. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.ymthe.2019.02.012. PMID 30846391. (anglicky) 
  • VERBEKE, Rein; LENTACKER, Ine; DE SMEDT, Stefaan C. Three decades of messenger RNA vaccine development. Nano Today. 2019-10, roč. 28, s. 100766. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.nantod.2019.100766. (anglicky) 
  • MOGHIMI, S. Moein. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Molecular Therapy. 2021-03, roč. 29, čís. 3, s. 898–900. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.ymthe.2021.01.030. PMID 33571463. (anglicky) 
  • O'REILLY, Peter. A phase III study to investigate a vaccine against COVID-19. [s.l.]: [s.n.] Dostupné online. DOI 10.1186/isrctn89951424. (anglicky) Type: dataset DOI: 10.1186/ISRCTN89951424. 
  • WU, Shipo; ZHONG, Gongxun; ZHANG, Jun. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nature Communications. 2020-12, roč. 11, čís. 1, s. 4081. Dostupné online [cit. 2021-11-22]. ISSN 2041-1723. DOI 10.1038/s41467-020-17972-1. PMID 32796842. (anglicky) 
  • PETROVSKY, Nikolai; AGUILAR, Julio César. Vaccine adjuvants: Current state and future trends. Immunology & Cell Biology. 2004-10, roč. 82, čís. 5, s. 488–496. Dostupné online [cit. 2021-11-22]. ISSN 0818-9641. DOI 10.1111/j.0818-9641.2004.01272.x. (anglicky) 
  • MUDGAL, Rajat; NEHUL, Sanketkumar; TOMAR, Shailly. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2. Human Vaccines & Immunotherapeutics. 2020-12-01, roč. 16, čís. 12, s. 2921–2931. Dostupné online [cit. 2021-11-22]. ISSN 2164-5515. DOI 10.1080/21645515.2020.1805992. PMID 32931361. (anglicky) 
  • RHEE, Joon Haeng. Current and New Approaches for Mucosal Vaccine Delivery. [s.l.]: Elsevier Dostupné online. ISBN 978-0-12-811924-2. DOI 10.1016/b978-0-12-811924-2.00019-5. S. 325–356. (anglicky) DOI: 10.1016/B978-0-12-811924-2.00019-5. 
  • THORP, H. Holden. Underpromise, overdeliver. Science. 27 March 2020, s. 1405. DOI 10.1126/science.abb8492. PMID 32205459. Bibcode 2020Sci...367.1405T. 
  • IWASAKI, Akiko; YANG, Yexin. The potential danger of suboptimal antibody responses in COVID-19. Nature Reviews Immunology. 21 April 2020, s. 339–41. ISSN 1474-1733. DOI 10.1038/s41577-020-0321-6. PMID 32317716. 
  • LANE, Richard. Sarah Gilbert: carving a path towards a COVID-19 vaccine. S. 1247. The Lancet [online]. 2020-04-18 [cit. 2020-10-28]. Roč. 395, čís. 10232, s. 1247. Dostupné online. DOI 10.1016/S0140-6736(20)30796-0. (anglicky) 
  • AMANAT, Fatima; KRAMMER, Florian. SARS-CoV-2 Vaccines: Status Report. S. 583–589. Immunity [online]. 2020-04 [cit. 2020-10-28]. Roč. 52, čís. 4, s. 583–589. Dostupné online. DOI 10.1016/j.immuni.2020.03.007. PMID 32259480. (anglicky) 
  • LUKE, Thomas; WU, Hua; ZHAO, Jincun; CHANNAPPANAVAR, Rudragouda; COLEMAN, Christopher M.; JIAO, Jin-An; MATSUSHITA, Hiroaki. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. S. 326ra21–326ra21. Science Translational Medicine [online]. 2016-02-17 [cit. 2020-10-28]. Roč. 8, čís. 326, s. 326ra21–326ra21. Dostupné online. DOI 10.1126/scitranslmed.aaf1061. PMID 26888429. (anglicky) 
  • BRAY, Natasha. Cattle engineered to produce human antibodies against coronavirus. S. 234. Nature Reviews Drug Discovery [online]. 2016-04 [cit. 2020-10-28]. Roč. 15, čís. 4, s. 234. Dostupné online. DOI 10.1038/nrd.2016.59. PMID 27032835. (anglicky) 
  • BALAKRISHNAN, Vijay Shankar. The arrival of Sputnik V. S. 1128. The Lancet Infectious Diseases [online]. 2020-10-01 [cit. 2021-01-03]. Roč. 20, čís. 10, s. 1128. Dostupné online. DOI 10.1016/S1473-3099(20)30709-X. (anglicky) 
  • VAN DOREMALEN, Neeltje; LAMBE, Teresa; SPENCER, Alexandra; BELIJ-RAMMERSTORFER, Sandra; PURUSHOTHAM, Jyothi N.; PORT, Julia R.; AVANZATO, Victoria A. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. S. 578–582. Nature [online]. 2020-10-22 [cit. 2020-11-20]. Roč. 586, čís. 7830, s. 578–582. Dostupné online. DOI 10.1038/s41586-020-2608-y. (anglicky) 
  • PARDI, Norbert; HOGAN, Michael J.; PORTER, Frederick W.; WEISSMAN, Drew. mRNA vaccines — a new era in vaccinology. S. 261–279. Nature Reviews Drug Discovery [online]. 2018-04 [cit. 2020-12-28]. Roč. 17, čís. 4, s. 261–279. Dostupné online. DOI 10.1038/nrd.2017.243. (anglicky) 
  • LIU, Yang; LIU, Jianying; XIA, Hongjie; ZHANG, Xianwen; FONTES-GARFIAS, Camila R.; SWANSON, Kena A.; CAI, Hui. Neutralizing Activity of BNT162b2-Elicited Serum. S. 1466–1468. New England Journal of Medicine [online]. 2021-04-15. Roč. 384, čís. 15, s. 1466–1468. Dostupné online. DOI 10.1056/NEJMc2102017. (anglicky) 
  • DEMONBREUN, Alexis R.; SANCILIO, Amelia; VELEZ, Matt P.; RYAN, Daniel T.; SABER, Rana; VAUGHT, Lauren A.; REISER, Nina L. Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.. S. 101018. EClinicalMedicine [online]. 2021-08. Roč. 38, s. 101018. Dostupné online. DOI 10.1016/j.eclinm.2021.101018. (anglicky) 
  • FRANCO-PAREDES, Carlos. Transmissibility of SARS-CoV-2 among fully vaccinated individuals. The Lancet Infectious Diseases. 2022-01-01, roč. 22, čís. 1, s. 16. PMID: 34953540. Dostupné online [cit. 2023-03-30]. ISSN 1473-3099. DOI 10.1016/S1473-3099(21)00768-4. PMID 34953540. (anglicky) 
  • SINGANAYAGAM, Anika; HAKKI, Seran; DUNNING, Jake. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases. 2022-02, roč. 22, čís. 2, s. 183–195. Dostupné online [cit. 2023-03-31]. DOI 10.1016/S1473-3099(21)00648-4. PMID 34756186. (anglicky) 
  • WILDER-SMITH, Annelies. What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?. The Lancet Infectious Diseases. 2022-02, roč. 22, čís. 2, s. 152–153. Dostupné online [cit. 2023-03-31]. DOI 10.1016/S1473-3099(21)00690-3. PMID 34756187. (anglicky) 
  • BERGWERK, Moriah; GONEN, Tal; LUSTIG, Yaniv. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. The New England Journal of Medicine. 2021-10-14, roč. 385, čís. 16, s. 1474–1484. PMID: 34320281 PMCID: PMC8362591. Dostupné online [cit. 2023-03-31]. ISSN 1533-4406. DOI 10.1056/NEJMoa2109072. PMID 34320281. (anglicky) 
  • REGEV-YOCHAY, Gili; GONEN, Tal; GILBOA, Mayan. Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron. New England Journal of Medicine. 2022-04-07, roč. 386, čís. 14, s. 1377–1380. Dostupné online [cit. 2023-03-31]. ISSN 0028-4793. DOI 10.1056/nejmc2202542. PMID 35297591. (anglicky) 
  • HAGAN, Liesl M.; MCCORMICK, David W.; LEE, Christine. Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021. MMWR. Morbidity and mortality weekly report. 2021-09-24, roč. 70, čís. 38, s. 1349–1354. PMID: 34555009 PMCID: PMC8459894. Dostupné online [cit. 2023-03-31]. ISSN 1545-861X. DOI 10.15585/mmwr.mm7038e3. PMID 34555009. (anglicky) 
  • ACHARYA, Charlotte B; SCHROM, John; MITCHELL, Anthea M. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant. Open Forum Infectious Diseases. 2022-05-01, roč. 9, čís. 5, s. ofac135. Dostupné online [cit. 2023-03-31]. ISSN 2328-8957. DOI 10.1093/ofid/ofac135. PMID 35479304. (anglicky) 
  • SHRESTHA, Nabin K.; BURKE, Patrick C.; NOWACKI, Amy S. Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine. dx.doi.org [online]. 2022-12-19 [cit. 2023-04-08]. Dostupné online. (anglicky) 
  • BARDOSH, Kevin; KRUG, Allison; JAMROZIK, Euzebiusz. COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities. Journal of Medical Ethics. 2022-12-05. PMID: 36600579. Dostupné online [cit. 2023-03-31]. ISSN 0306-6800. DOI 10.1136/jme-2022-108449. PMID 36600579. (anglicky) 
  • LAM, Leo L.; NICHOLS, Taylor. Ethics of college vaccine mandates, using reasonable comparisons. Journal of Medical Ethics. 2023-03-30. PMID: 36997309. Dostupné online [cit. 2023-04-23]. ISSN 0306-6800. DOI 10.1136/jme-2022-108852. PMID 36997309. (anglicky) 
  • ANDREWS, Nick; STOWE, Julia; KIRSEBOM, Freja. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. The New England Journal of Medicine. 2022-03-02, s. NEJMoa2119451. PMID: 35249272 PMCID: PMC8908811. Dostupné online [cit. 2023-04-02]. ISSN 0028-4793. DOI 10.1056/NEJMoa2119451. PMID 35249272. (anglicky) 
  • IRRGANG, Pascal; GERLING, Juliane; KOCHER, Katharina. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science Immunology. 2023-01-27, roč. 8, čís. 79, s. eade2798. Dostupné online [cit. 2023-04-20]. ISSN 2470-9468. DOI 10.1126/sciimmunol.ade2798. PMID 36548397. (anglicky) 
  • POLACK, Fernando P.; THOMAS, Stephen J.; KITCHIN, Nicholas; ABSALON, Judith; GURTMAN, Alejandra; LOCKHART, Stephen; PEREZ, John L. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. S. 2603–2615. New England Journal of Medicine [online]. 2020-12-31 [cit. 2021-01-03]. Roč. 383, čís. 27, s. 2603–2615. Dostupné online. DOI 10.1056/NEJMoa2034577. (anglicky) 
  • BADEN, Lindsey R.; EL SAHLY, Hana M.; ESSINK, Brandon; KOTLOFF, Karen; FREY, Sharon; NOVAK, Rick; DIEMERT, David. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine [online]. 2020-12-30 [cit. 2021-01-03]. Dostupné online. DOI 10.1056/NEJMoa2035389. (anglicky) 
  • OLIVER, Sara E.; GARGANO, Julia W.; MARIN, Mona; WALLACE, Megan; CURRAN, Kathryn G.; CHAMBERLAND, Mary; MCCLUNG, Nancy. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020. MMWR. Morbidity and Mortality Weekly Report. December 2020, s. 1653–1656. Dostupné online. DOI 10.15585/mmwr.mm695152e1. PMID 33382675. 
  • LOGUNOV, Denis Y; DOLZHIKOVA, Inna V; SHCHEBLYAKOV, Dmitry V; TUKHVATULIN, Amir I; ZUBKOVA, Olga V; DZHARULLAEVA, Alina S; KOVYRSHINA, Anna V. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. S. 671–681. The Lancet [online]. 2021-02. Roč. 397, čís. 10275, s. 671–681. Dostupné online. DOI 10.1016/S0140-6736(21)00234-8. (anglicky) 
  • Burki TK. The Russian vaccine for COVID-19. The Lancet. Respiratory Medicine. November 2020, s. e85–e86. Dostupné online. DOI 10.1016/S2213-2600(20)30402-1. PMID 32896274. 
  • ZHU, Feng-Cai; GUAN, Xu-Hua; LI, Yu-Hua; HUANG, Jian-Ying; JIANG, Tao; HOU, Li-Hua; LI, Jing-Xin. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. S. 479–488. The Lancet [online]. 2020-08 [cit. 2021-02-25]. Roč. 396, čís. 10249, s. 479–488. Dostupné online. DOI 10.1016/S0140-6736(20)31605-6. (anglicky) 
  • DAG BERILD, Jacob; BERGSTAD LARSEN, Vilde; MYRUP THIESSON, Emilia. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries. JAMA Network Open. 2022-06-14, roč. 5, čís. 6, s. e2217375. Dostupné online [cit. 2023-04-20]. ISSN 2574-3805. DOI 10.1001/jamanetworkopen.2022.17375. PMID 35699955. (anglicky) 
  • GAO, Feng-Xia; WU, Rui-Xin; SHEN, Mei-Ying. Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice. iScience. 2022-12-22, roč. 25, čís. 12, s. 105479. Dostupné online [cit. 2023-04-08]. ISSN 2589-0042. DOI 10.1016/j.isci.2022.105479. (anglicky) 
  • KING, Jeff; FERRAZ, Octávio Luiz Motta; JONES, Andrew. Mandatory COVID-19 vaccination and human rights. The Lancet. 2022-01-15, roč. 399, čís. 10321, s. 220–222. PMID: 34953527. Dostupné online [cit. 2023-03-30]. ISSN 0140-6736. DOI 10.1016/S0140-6736(21)02873-7. PMID 34953527. (anglicky) 
  • CHENG, F. K. Debate on mandatory COVID-19 vaccination. Ethics, Medicine, and Public Health. 2022-04, roč. 21, s. 100761. PMID: 35097181. Dostupné online [cit. 2023-03-30]. DOI 10.1016/j.jemep.2022.100761. PMID 35097181. (anglicky) 
  • KMIETOWICZ, Zosia. Evidence is insufficient to back mandatory NHS staff vaccination, says House of Lords committee. BMJ. 2021-12-03, roč. 375, s. n2957. Dostupné online [cit. 2023-03-30]. ISSN 1756-1833. DOI 10.1136/bmj.n2957. (anglicky) 
  • FRAIMAN, Joseph; ERVITI, Juan; JONES, Mark. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022-09-22, roč. 40, čís. 40, s. 5798–5805. PMID: 36055877 PMCID: PMC9428332. Dostupné online [cit. 2023-03-30]. ISSN 1873-2518. DOI 10.1016/j.vaccine.2022.08.036. PMID 36055877. (anglicky) 

dw.com

  • Coronavirus vaccine: EU reaches deal with Pfizer, BioNTech. DW.COM [online]. 2020-11-10. Dostupné online. 

echo24.cz

  • TRAN, Viet. Odstrašující příklad digitalizace. Český systém očkování má stále chyby, zdržuje praktiky. Echo24 [online]. 2021-03-09 [cit. 2021-03-11]. Dostupné online. 
  • kap. Až milion podezření na nežádoucí účinky vakcín proti covidu. Europoslankyně žádá odškodnění - Echo24.cz. echo24.cz [online]. ECHO MEDIA, 2021-11-06 [cit. 2023-04-11]. Dostupné online. 
  • KAISER, Daniel. Vakcína proti covidu – horší, než jsme si mysleli. echo24.cz [online]. ECHO MEDIA, 2023-01-18 [cit. 2023-04-20]. Dostupné online. 

efe.com

  • STAFF, Agencia EFE. La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19. Agencia EFE. 31 December 2020. Dostupné online. (španělsky) 

elsevier.com

linkinghub.elsevier.com

emirateswoman.com

  • Dubai approves the Pfizer-BioNTech vaccine which will be free of charge [online]. 23 December 2020 [cit. 2020-12-28]. Dostupné online. 

euractiv.com

  • Russia files for Sputnik vaccine registration in EU. Euractiv.com [online]. 2021-01-20. Dostupné online. 

euronews.com

  • GSK-Sanofi says its COVID-19 vaccine won't be ready until late 2021. euronews.com [online]. 2020-12-11 [cit. 2021-01-03]. Dostupné online. (anglicky) 
  • LIBOREIRO, Jorge; PITCHERS, Christopher. How a court ruling lays the ground for mandatory COVID-19 vaccination. euronews.com [online]. 2021-04-13 [cit. 2022-01-10]. Dostupné online. (anglicky) 

europa.eu

ema.europa.eu

  • COVID-19 medicines | European Medicines Agency (EMA). www.ema.europa.eu [online]. [cit. 2024-08-15]. Dostupné online. (anglicky) 
  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021, EMA News, 12.3.2021
  • EMA starts rolling review of the Sputnik V COVID-19 vaccine. www.ema.europa.eu [online]. European Medicines Agency, 2021-03-04. Dostupné online. 
  • Comirnaty EPAR [online]. [cit. 2020-12-23]. Dostupné online. 
  • European Medicines Agency: EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.
  • COVID-19 vaccines safety update: Comirnaty (BioNTech Manufacturing GmbH), COVID-19 Vaccine Janssen (Janssen-Cilag International NV), Nuvaxovid (Novavax CZ, a.s.), Spikevax (Moderna Biotech Spain, S.L.), Vaxzevria (AstraZeneca AB). www.ema.europa.eu [online]. European Medicines Agency (EMA), 2022-01-20 [cit. 2023-03-30]. Dostupné online. (anglicky) 

ec.europa.eu

europarl.europa.eu

  • JORON, Virginie. Návrh usnesení o zřízení Evropského fondu pro odškodnění obětí očkování proti onemocnění COVID-19. www.europarl.europa.eu [online]. Evropský parlament, 2021-09-23 [cit. 2023-04-11]. Dostupné online. 
  • VIRGINIE, Joron; BRUNA, Annika; BUCHHEIT, Markus, et al. MOTION FOR A RESOLUTION on creating a European compensation fund for victims of the COVID-19 vaccines. www.europarl.europa.eu [online]. European Parliament, 2022-03-17 [cit. 2023-04-11]. Dostupné online. (anglicky) 

commission.europa.eu

  • Bezpečné vakcíny proti covidu-19 pro Evropu. commission.europa.eu [online]. [cit. 2023-03-28]. Dostupné online. 

farsnews.ir

  • Iran Licenses Emergency Injection of Home-Made Anti-Coronavirus Vaccine | Farsnews Agency. www.farsnews.ir [online]. [cit. 2021-11-22]. Dostupné online. 

faz.net

fda.gov

  • FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine [online]. Úřad pro kontrolu potravin a léčiv, 2020-12-18 [cit. 2020-12-28]. Dostupné online. (anglicky) 
  • FDA Approves First COVID-19 Vaccine [online]. FDA, 2021-08-23 [cit. 2021-09-23]. Dostupné online. (anglicky) 
  • {{{publisher}}}: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.

financialtribune.com

  • Iran Launches Phase Two of Mass Inoculation Campaign [online]. 22 February 2021 [cit. 2021-02-23]. Dostupné online. (En) 

forbes.com

  • JENNINGS, Katie. How Much Will A Covid-19 Vaccine Cost? [online]. 17 November 2020 [cit. 2020-12-06]. Dostupné online. 

fortune.com

  • It’s not just Johnson & Johnson: China has a single-dose COVID-19 vaccine that’s 65% effective. Fortune [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 

france24.com

  • Jordan approves Pfizer-BioNTech Covid vaccine [online]. France 24, 15 December 2020 [cit. 2020-12-15]. Dostupné online. 
  • Chile aprueba el uso de emergencia de la vacuna china de Sinovac contra covid-19. france24.com [online]. 2021-01-20 [cit. 2021-02-25]. Dostupné online. (španělsky) 

gatesfoundation.org

  • Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world. Bill & Melinda Gates Foundation. 9 December 2020. Dostupné online [cit. 11 December 2020]. 

gatesnotes.com

  • GATES, Bill. The vaccine race explained: What you need to know about the COVID-19 vaccine [online]. The Gates Notes, 30 April 2020 [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 14 May 2020. 
  • What you need to know about the COVID-19 vaccine | Bill Gates. web.archive.org [online]. 2020-05-14 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-05-14. 
  • GATES, Bill. The first modern pandemic: The scientific advances we need to stop COVID-19 [online]. The Gates Notes, 23 April 2020 [cit. 2020-05-06]. Dostupné v archivu pořízeném z originálu dne 13 May 2020. 

gavi.org

  • Key Outcomes: COVAX AMC [online]. Gavi. Dostupné online. 
  • What is COVAX? [online]. GAVI, 2020-09-01 [cit. 2020-12-11]. Dostupné online. 
  • What are viral vector-based vaccines and how could they be used against COVID-19?. www.gavi.org [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 

globalcommissionforpostpandemicpolicy.org

  • COVID-19 vaccine production, to January 31st 2022. Global Commission for Post-Pandemic Policy [online]. 2022 [cit. 2022-04-05]. Dostupné online. (anglicky) 

globo.com

g1.globo.com

  • Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil [online]. G1, 23 February 2021 [cit. 2021-02-23]. Dostupné online. (portugalsky) 

glopid-r.org

  • GloPID: Novel coronavirus COVID-19 [online]. [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 2 May 2020. 

go.com

abcnews.go.com

  • Haley Yamada; JON SCHLOSBERG; SENI TIENABESO. Bill and Melinda Gates Foundation announces $250 million COVID vaccine commitment. ABC News - Technology. 10 December 2020. Dostupné online [cit. 11 December 2020]. 
  • NEWS, A. B. C. Turkish official says CoronaVac vaccine 91.25% effective. ABC News [online]. [cit. 2021-01-13]. Dostupné online. (anglicky) 
  • Bahrain becomes 1st nation to grant J&J shot emergency use. ABC News. 25 February 2021. Dostupné online [cit. 25 February 2021]. 

gob.mx

  • SANITARIOS, Comisión Federal para la Protección contra Riesgos. AUTORIZACIÓN PARA USO DE EMERGENCIA A VACUNA ASTRAZENECA COVID-19 [online]. [cit. 2021-01-05]. Dostupné online. (španělsky) 

gouv.mc

en.gouv.mc

  • FIRST VACCINES ARRIVE IN MONACO - COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement - Monaco [online]. [cit. 2021-02-19]. Dostupné online. 

gov.uk

  • UK medicines regulator gives approval for first UK COVID-19 vaccine [online]. Medicines and Healthcare Products Regulatory Agency, Government of the UK, 2 December 2020 [cit. 2020-12-02]. Dostupné online. 
  • Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine [online]. 8 December 2020 [cit. 2020-12-13]. Dostupné online. 
  • Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine [online]. 3 December 2020 [cit. 2020-12-13]. Dostupné online. 
  • Information for Healthcare Professionals on COVID-19 Vaccine Moderna [online]. 8 January 2021 [cit. 2021-01-08]. Dostupné online. 
  • Conditions of Authorisation for COVID-19 Vaccine Moderna [online]. 8 January 2021 [cit. 2021-01-09]. Dostupné online. 
  • Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca [online]. 30 December 2020 [cit. 2021-01-04]. Dostupné online. 
  • Department of Health and Social Care: Oxford University/AstraZeneca vaccine authorised by UK medicines regulator, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.
  • Conditions of Authorisation for COVID-19 Vaccine AstraZeneca [online]. 30 December 2020 [cit. 2021-01-04]. Dostupné online. 

gov.vc

  • Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021 [online]. 11 February 2021 [cit. 2021-02-12]. Dostupné online. 

govern.ad

  • ANDORRA COVID-19 [online]. [cit. 2021-02-19]. Dostupné online. 

gulfnews.com

  • AstraZeneca and Moderna vaccines to be administered in Saudi Arabia [online]. [cit. 2021-01-19]. Dostupné online. (anglicky) 
  • COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs. Gulf News. Dostupné online [cit. 24 February 2021]. 

harvard.edu

adsabs.harvard.edu

health.govt.nz

  • Robust assessment ahead of Medsafe approval of vaccine [online]. 3 February 2021 [cit. 2021-02-06]. Dostupné online. 

hindustantimes.com

  • MANRAL, Karan. Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine. Hindustan Times. 4 March 2021. Dostupné online [cit. 6 March 2021]. 

hln.be

  • BOSSAERT, Jeroen. Zoveel gaan we betalen voor de coronavaccins: staatssecretaris zet confidentiële prijzen per ongeluk online [online]. 17 December 2020 [cit. 2020-12-18]. Dostupné online. 

idnes.cz

  • Rusko má druhou vakcínu proti covidu a na cestě je třetí, oznámil Putin. iDNES.cz [online]. MAFRA, 2020-10-14 [cit. 2020-10-28]. Dostupné online. 
  • Naše vakcína proti covidu má účinnost 94,5 procenta, hlásí firma Moderna. iDNES.cz [online]. 2020-11-16. Dostupné online. 
  • Účinnost vakcíny je 95 procent, upřesnil Pfizer. Zažádá o její nasazení. iDNES.cz [online]. 2020-11-18 [cit. 2020-11-20]. Dostupné online. (anglicky) 
  • Maďarsko jako první v EU předběžně schválilo ruskou vakcínu Sputnik [online]. [cit. 2021-01-22]. Dostupné online. 
  • USA schválily jednodávkovou vakcínu J&J, vydrží až tři měsíce v lednici. iDNES [online]. 2021-02-28 [cit. 2021-02-28]. Dostupné online. 
  • VLČKOVÁ, Tereza. Očkovací centra, vakcína i technologie. Co všechno nám oproti Izraeli chybí?. [[iDNES.cz|iDNES.cz]] [online]. MAFRA, 2021-01-15 [cit. 2021-01-16]. Dostupné online. 
  • Znehodnocené vakcíny. V Česku přišlo vniveč 664 očkovacích dávek. iDNES.cz [online]. MAFRA, 2021-03-11 [cit. 2021-03-11]. Dostupné online. 
  • Česká vakcína proti covidu prošla první fází. Je bezpečná, tvrdí vědci, iDNES, 23.9.2021
  • Rakousko přerušilo očkování vakcínou AstraZeneca. Vyšetřuje smrt zdravotnice. iDNES.cz [online]. 2021-03-07. Dostupné online. 
  • „Počet lidí, u kterých se po očkování objevila trombóza, není vyšší než jejich počet v běžné populaci,“. iDNES.cz [online]. MAFRA a.s., 2021-03-16 [cit. 2021-10-27]. Dostupné online. 
  • JUŠKOVÁ, Kamila. Další vakcíny proti covidu nemají smysl. Může hrozit těžší průběh, říká imunolog. iDNES.cz [online]. 2023-04-19 [cit. 2023-04-27]. Dostupné online. 
  • REŽŇÁKOVÁ, Lada. Povinné covidové očkování: stačí změna vyhlášky, odmítačům hrozí pokuta. iDNES.cz [online]. MAFRA [cit. 28.11.2021]. Dostupné online. 

ina-registry.org

  •  :: Welcome Indonesia Registry Center ::. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 

indiablooms.com

  • Uruguay to start covid 19 Vaccination in April 2021. India Blooms. Dostupné online. 

indiatoday.in

  • CHAUHAN, Chanchal. Coronavirus vaccine news: CureVac's vaccine triggers immune response, UK begins review for AstraZeneca's drug. indiatoday.in [online]. 2020-11-03 [cit. 2021-01-03]. Dostupné online. (anglicky) 

investicniweb.cz

  • Německá firma CureVac brzy zahájí třetí fázi testování vakcíny. investicniweb.cz [online]. 2020-11-12 [cit. 2020-11-20]. Dostupné online. 

iprima.cz

cnn.iprima.cz

  • ČTK. Po očkování proti covidu zemřelo v Česku už 39 lidí. Úřady prošetřují souvislost. cnn.iprima.cz [online]. FTV Prima spol. s r.o, 2021-04-15 [cit. 2023-04-02]. Dostupné online. 
  • K věci, Zdeněk Hostomský. cnn.iprima.cz [online]. FTV Prima spol. s r.o., 2024-02-27 [cit. 2024-10-08]. Dostupné online. 

irna.ir

en.irna.ir

  • Iran issues permit for emergency use for three other COVID-19 vaccines: Official. IRNA English. 17 February 2021. Dostupné online. (anglicky) 

irozhlas.cz

isrctn.com

ivi.int

  • IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea [online]. [cit. 2021-11-22]. Dostupné online. (anglicky) 

jamanetwork.com

janssen.com

japantimes.co.jp

  • OTAKE, Tomoko. Japan reports first death directly linked to COVID-19 vaccine. The Japan Times [online]. 2023-03-10 [cit. 2023-04-24]. Dostupné online. (anglicky) 

jpost.com

  • Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine [online]. [cit. 2020-12-28]. Dostupné online. 

kathmandupost.com

  • POUDEL, Arjun. China's Shinopharm vaccine gets emergency use authorisation in Nepal [online]. Kathmandu Post [cit. 2021-02-19]. Dostupné online. (English) 

khaleejtimes.com

  • UAE approves Russia's Sputnik vaccine for emergency use. Khaleej Times. 21 January 2021. Dostupné online [cit. 21 January 2021]. 

khmertimeskh.com

  • RINITH, Taing. Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine [online]. Khmer Times, 4 February 2021 [cit. 2021-02-04]. Dostupné online. 

laegemiddelstyrelsen.dk

  • Lægemiddelstyrelsen: Første vaccine mod COVID19 godkendt i EU, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.
  • Endnu en vaccine mod COVID-19 er godkendt af EU-Kommissionen [online]. [cit. 2021-01-07]. Dostupné online. (dánsky) 

lanacion.com.ar

  • Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer [online]. [cit. 2020-12-23]. Dostupné online. (španělsky) 

legemiddelverket.no

  • Norwegian authorization">Statens legemiddelverk: Koronavaksinen fra BioNTech og Pfizer (Comirnaty) får betinget godkjenning i Europa., tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line. Archivováno 8. 1. 2021 na Wayback Machine.
  • Status på koronavaksiner under godkjenning per 6. januar 2021 [online]. [cit. 2021-01-07]. Dostupné online. (norsky (bokmål)) 

lidovky.cz

  • Jak účinná je ‚česká‘ vakcína pro lidi, kteří mají z očkování strach? Na dávku už čekají tisíce zájemců | Domov. Lidovky.cz [online]. 2022-02-02 [cit. 2024-08-15]. Dostupné online. 
  • Nedostatek vakcín v Česku? Přerušte očkování, doporučilo ministerstvo. Podle Blatného a Babiše ale oznámení neplatí. Lidovky.cz [online]. 2021-01-27. Dostupné online. 

lyfjastofnun.is

  • Icelandic authorization">Lyfjastofnun: COVID-19: Bóluefninu Comirnaty frá BioNTech/Pfizer hefur verið veitt skilyrt íslenskt markaðsleyfi., tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.
  • COVID-19: Bóluefninu COVID-19 Vaccine Moderna frá hefur verið veitt skilyrt íslenskt markaðsleyfi [online]. [cit. 2021-01-07]. Dostupné online. (islandsky) 

medicalxpress.com

  • KIRKA, Danica. AstraZeneca manufacturing error clouds vaccine study results. medicalxpress.com [online]. 2020-11-25 [cit. 2020-12-28]. Dostupné online. (anglicky) 
  • Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy. medicalxpress.com [online]. 2020-12-31 [cit. 2021-01-03]. Dostupné online. (anglicky) 
  • Pfizer vaccine results published in peer-reviewed journal. medicalxpress.com [online]. 2020-12-10 [cit. 2020-12-28]. Dostupné online. (anglicky) 
  • Study suggests those who had COVID-19 may only need one vaccine dose. medicalxpress.com [online]. 2021-04-15 [cit. 2022-01-10]. Dostupné online. (anglicky) 
  • Unvaccinated people twice as likely to be reinfected with COVID: study. medicalxpress.com [online]. 2021-08-06 [cit. 2022-01-10]. Dostupné online. (anglicky) 
  • MISHRA, Sanjay. Can people vaccinated against COVID-19 still spread the coronavirus?. medicalxpress.com [online]. 2021-05-26 [cit. 2022-01-10]. Dostupné online. (anglicky) 
  • NEERGAARD, Lauran; JOHNSON, Linda A. 'Simple is beautiful': One-shot vaccine proves effective. medicalxpress.com [online]. 2021-01-29 [cit. 2021-02-25]. Dostupné online. (anglicky) 
  • MILKO, Victoria; WU, Huizhong. Study: Sinopharm COVID-19 vaccines appear safe, effective. medicalxpress.com [online]. 2021-05-27 [cit. 2022-01-10]. Dostupné online. (anglicky) 
  • COVID vaccine-makers largely protected on side effects. medicalxpress.com [online]. 2021-04-20 [cit. 2022-01-10]. Dostupné online. (anglicky) 

medigenvac.com

medrxiv.org

minsalud.gob.bo

  • Ministerio de Salud de Bolivia - Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19. www.minsalud.gob.bo. Dostupné online [cit. 1 January 2021]. 

modernatx.com

investors.modernatx.com

  • Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel [online]. modernatx.com, 4 January 2021 [cit. 2021-01-04]. Dostupné online. 

moz.gov.ua

msn.com

  • Iraq grants emergency approval for Pfizer COVID-19 vaccine [online]. MSN [cit. 2020-12-27]. Dostupné online. 
  • Khairy: Malaysia can use Pfizer’s Covid-19 vaccine now as conditional registration granted. www.msn.com [online]. [cit. 2021-01-09]. Dostupné online. 

mzcr.cz

onemocneni-aktualne.mzcr.cz

  • KOMENDA, M.; PANOŠKA, P.; BULHART, V., a kol. COVID‑19: Přehled aktuální situace v ČR. Onemocnění aktuálně [online]. Ministerstvo zdravotnictví ČR, vývoj: Ústav zdravotnických informací a statistiky ČR a Institut biostatistiky a analýz Lékařské fakulty Masarykovy univerzity, 2020 [cit. 2024-09-07]. Dostupné v archivu pořízeném z originálu dne 2020-11-30. ISSN 2694-9423. 
  • DAŇKOVÁ, Šárka; ZVOLSKÝ, Miroslav; DUŠEK, Ladislav. Mortalitní data, kódování a vymezení úmrtí na COVID-19. Onemocnění aktuálně [online]. Ministerstvo zdravotnictví ČR, vývoj: Ústav zdravotnických informací a statistiky ČR a Institut biostatistiky a analýz Lékařské fakulty Masarykovy univerzity, 2020-11-02 [cit. 2024-10-02]. Dostupné online. 

mzcr.cz

koronavirus.mzcr.cz

  • Očkování proti covid-19: Spolehlivá cesta k běžnému životu – Aktuální informace o COVID-19. koronavirus.mzcr.cz [online]. [cit. 2021-01-15]. Dostupné online. 

n1info.com

rs.n1info.com

  • Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju. N1. 31 December 2020. Dostupné online. (srbsky) 

nationalpost.com

  • Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU [online]. Dostupné online. 

nature.com

ncronline.org

  • MCELWEE, Joshua J. Vatican to offer coronavirus vaccine to residents and staff in early 2021. www.ncronline.org. National Catholic Reporter, December 11, 2020. Dostupné online [cit. February 9, 2021]. 

nejm.org

  • LIU, Yang; LIU, Jianying; XIA, Hongjie; ZHANG, Xianwen; FONTES-GARFIAS, Camila R.; SWANSON, Kena A.; CAI, Hui. Neutralizing Activity of BNT162b2-Elicited Serum. S. 1466–1468. New England Journal of Medicine [online]. 2021-04-15. Roč. 384, čís. 15, s. 1466–1468. Dostupné online. DOI 10.1056/NEJMc2102017. (anglicky) 
  • POLACK, Fernando P.; THOMAS, Stephen J.; KITCHIN, Nicholas; ABSALON, Judith; GURTMAN, Alejandra; LOCKHART, Stephen; PEREZ, John L. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. S. 2603–2615. New England Journal of Medicine [online]. 2020-12-31 [cit. 2021-01-03]. Roč. 383, čís. 27, s. 2603–2615. Dostupné online. DOI 10.1056/NEJMoa2034577. (anglicky) 
  • BADEN, Lindsey R.; EL SAHLY, Hana M.; ESSINK, Brandon; KOTLOFF, Karen; FREY, Sharon; NOVAK, Rick; DIEMERT, David. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine [online]. 2020-12-30 [cit. 2021-01-03]. Dostupné online. DOI 10.1056/NEJMoa2035389. (anglicky) 

neweurope.eu

  • BAUBEKOVA, Akdana. Kazakhstan begins mass vaccination by Russian Sputnik V. neweurope.eu [online]. 2021-02-01 [cit. 2021-02-25]. Dostupné v archivu pořízeném z originálu dne 2021-02-09. (anglicky) 

news24.com

  • Covid-19: Zimbabwe authorises Sputnik V, Sinovac vaccines for emergency use. www.news24.com. news24.com, 9 March 2021. Dostupné online. 

newsd.in

  • WHO clears Pfizer-BioNTech coronavirus vaccine for emergency use [online]. 2021-01-01 [cit. 2021-01-01]. Dostupné online. 

nhs.uk

nih.gov

ncbi.nlm.nih.gov

  • Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science. December 2020, s. 104. DOI 10.1186/s12929-020-00695-2. PMID 33341119. 
  • Subbarao K. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host & Microbe. July 2021, s. 1111–1123. DOI 10.1016/j.chom.2021.06.016. PMID 34265245. 
  • Mallapaty S, Callaway E, Kozlov M, Ledford H, Pickrell J, Van Noorden R. How COVID vaccines shaped 2021 in eight powerful charts. Nature. December 2021, s. 580–583. DOI 10.1038/d41586-021-03686-x. PMID 34916666. S2CID 245262732. Bibcode 2021Natur.600..580M. 
  • LE, Tung Thanh; CRAMER, Jakob P.; CHEN, Robert; MAYHEW, Stephen. Evolution of the COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 4 September 2020, s. 667–68. ISSN 1474-1776. DOI 10.1038/d41573-020-00151-8. PMID 32887942. S2CID 221503034. 
  • THANH LE, Tung; ANDREADAKIS, Zacharias; KUMAR, Arun; GÓMEZ ROMÁN, Raúl; TOLLEFSEN, Stig; SAVILLE, Melanie; MAYHEW, Stephen. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 9 April 2020, s. 305–06. ISSN 1474-1776. DOI 10.1038/d41573-020-00073-5. PMID 32273591. 
  • Gouglas D, Thanh Le T, Henderson K, Kaloudis A, Danielsen T, Hammersland NC, Robinson JM, Heaton PM, Røttingen JA. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study. Lancet Global Health. December 2018, s. e1386–96. DOI 10.1016/S2214-109X(18)30346-2. PMID 30342925. 
  • DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics. May 2016, s. 20–33. DOI 10.1016/j.jhealeco.2016.01.012. PMID 26928437. 
  • Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK. Ensuring global access to COVID‑19 vaccines. Lancet. May 2020, s. 1405–06. DOI 10.1016/S0140-6736(20)30763-7. PMID 32243778. 
  • Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology. December 2003, s. 567–82. DOI 10.1080/03079450310001621198. PMID 14676007. 
  • Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD, Bellini WJ, Barratt-Boyes S, Gambotto A. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet. December 2003, s. 1895–96. DOI 10.1016/S0140-6736(03)14962-8. PMID 14667748. 
  • Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, AlHajri F, Osterhaus AD, Haagmans BL, Gambotto A. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Vaccine. October 2014, s. 5975–82. DOI 10.1016/j.vaccine.2014.08.058. PMID 25192975. 
  • Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. The Journal of Infectious Diseases. February 2005, s. 507–14. DOI 10.1086/427242. PMID 15655773. 
  • Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. Journal of Virological Methods. September 2005, s. 21–28. DOI 10.1016/j.jviromet.2005.03.021. PMID 15885812. 
  • Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, Vogel L, Hayes N, Sullivan JL, Zaki S, Subbarao K, Ambrosino DM. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. The Journal of Infectious Diseases. March 2006, s. 685–92. DOI 10.1086/500143. PMID 16453264. 
  • Jiang S, Lu L, Du L. Development of SARS vaccines and therapeutics is still needed. Future Virology. January 2013, s. 1–2. DOI 10.2217/fvl.12.126. PMID 32201503. 
  • SHEHATA, Mahmoud M.; GOMAA, Mokhtar R.; ALI, Mohamed A.; KAYALI, Ghazi. Middle East respiratory syndrome coronavirus: a comprehensive review. Frontiers of Medicine. January 2016, s. 120–36. DOI 10.1007/s11684-016-0430-6. PMID 26791756. 
  • Butler D. SARS veterans tackle coronavirus. Nature. October 2012, s. 20. DOI 10.1038/490020a. PMID 23038444. Bibcode 2012Natur.490...20B. 
  • Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K, Reuschel EL, Robb ML, Racine T, Oh MD, Lamarre C, Zaidi FI, Boyer J, Kudchodkar SB, Jeong M, Darden JM, Park YK, Scott PT, Remigio C, Parikh AP, Wise MC, Patel A, Duperret EK, Kim KY, Choi H, White S, Bagarazzi M, May JM, Kane D, Lee H, Kobinger G, Michael NL, Weiner DB, Thomas SJ, Maslow JN. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet. Infectious Diseases. September 2019, s. 1013–22. DOI 10.1016/S1473-3099(19)30266-X. PMID 31351922. 
  • Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS. Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Frontiers in Microbiology. 2019, s. 1781. DOI 10.3389/fmicb.2019.01781. PMID 31428074. 
  • Gates B. Responding to Covid-19: A once-in-a-century pandemic?. The New England Journal of Medicine. February 2020, s. 1677–79. DOI 10.1056/nejmp2003762. PMID 32109012. 
  • Fauci AS, Lane HC, Redfield RR. Covid-19: Navigating the uncharted. The New England Journal of Medicine. March 2020, s. 1268–69. DOI 10.1056/nejme2002387. PMID 32109011. 
  • SIMPSON, Shmona; KAUFMANN, Michael C.; GLOZMAN, Vitaly; CHAKRABARTI, Ajoy. Disease X: accelerating the development of medical countermeasures for the next pandemic. The Lancet. Infectious Diseases. May 2020, s. e108–15. ISSN 1474-4457. DOI 10.1016/S1473-3099(20)30123-7. PMID 32197097. 
  • DIAMOND, Michael S; PIERSON, Theodore C. The challenges of vaccine development against a new virus during a pandemic. Cell Host and Microbe. 13 May 2020, s. 699–703. DOI 10.1016/j.chom.2020.04.021. PMID 32407708. 
  • ARBEITMAN, Claudia R.; ROJAS, Pablo; OJEDA-MAY, Pedro. The SARS-CoV-2 spike protein is vulnerable to moderate electric fields. Nature Communications. 2021-12, roč. 12, čís. 1, s. 5407. Dostupné online [cit. 2021-11-22]. ISSN 2041-1723. DOI 10.1038/s41467-021-25478-7. PMID 34518528. (anglicky) 
  • GRIFONI, Alba; WEISKOPF, Daniela; RAMIREZ, Sydney I. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020-06, roč. 181, čís. 7, s. 1489–1501.e15. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.cell.2020.05.015. PMID 32473127. (anglicky) 
  • DUTTA, Noton K.; MAZUMDAR, Kaushiki; GORDY, James T. The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development. Journal of Virology. 2020-06-16, roč. 94, čís. 13. Dostupné online [cit. 2021-11-22]. ISSN 0022-538X. DOI 10.1128/JVI.00647-20. PMID 32546606. (anglicky) 
  • NIKOLAIDIS, Marios; MARKOULATOS, Panayotis; VAN DE PEER, Yves. The Neighborhood of the Spike Gene Is a Hotspot for Modular Intertypic Homologous and Nonhomologous Recombination in Coronavirus Genomes. Molecular Biology and Evolution. 2021-10-12, s. msab292. Dostupné online [cit. 2021-11-22]. ISSN 0737-4038. DOI 10.1093/molbev/msab292. PMID 34638137. (anglicky) 
  • DIAMOND, Michael S.; PIERSON, Theodore C. The Challenges of Vaccine Development against a New Virus during a Pandemic. Cell Host & Microbe. 2020-05, roč. 27, čís. 5, s. 699–703. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.chom.2020.04.021. PMID 32407708. (anglicky) 
  • PARK, Kyung Soo; SUN, Xiaoqi; AIKINS, Marisa E. Non-viral COVID-19 vaccine delivery systems. Advanced Drug Delivery Reviews. 2021-02, roč. 169, s. 137–151. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.addr.2020.12.008. PMID 33340620. (anglicky) 
  • KOWALSKI, Piotr S.; RUDRA, Arnab; MIAO, Lei. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Molecular Therapy. 2019-04, roč. 27, čís. 4, s. 710–728. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.ymthe.2019.02.012. PMID 30846391. (anglicky) 
  • MOGHIMI, S. Moein. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Molecular Therapy. 2021-03, roč. 29, čís. 3, s. 898–900. Dostupné online [cit. 2021-11-22]. DOI 10.1016/j.ymthe.2021.01.030. PMID 33571463. (anglicky) 
  • WU, Shipo; ZHONG, Gongxun; ZHANG, Jun. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nature Communications. 2020-12, roč. 11, čís. 1, s. 4081. Dostupné online [cit. 2021-11-22]. ISSN 2041-1723. DOI 10.1038/s41467-020-17972-1. PMID 32796842. (anglicky) 
  • MUDGAL, Rajat; NEHUL, Sanketkumar; TOMAR, Shailly. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2. Human Vaccines & Immunotherapeutics. 2020-12-01, roč. 16, čís. 12, s. 2921–2931. Dostupné online [cit. 2021-11-22]. ISSN 2164-5515. DOI 10.1080/21645515.2020.1805992. PMID 32931361. (anglicky) 
  • THORP, H. Holden. Underpromise, overdeliver. Science. 27 March 2020, s. 1405. DOI 10.1126/science.abb8492. PMID 32205459. Bibcode 2020Sci...367.1405T. 
  • IWASAKI, Akiko; YANG, Yexin. The potential danger of suboptimal antibody responses in COVID-19. Nature Reviews Immunology. 21 April 2020, s. 339–41. ISSN 1474-1733. DOI 10.1038/s41577-020-0321-6. PMID 32317716. 
  • AMANAT, Fatima; KRAMMER, Florian. SARS-CoV-2 Vaccines: Status Report. S. 583–589. Immunity [online]. 2020-04 [cit. 2020-10-28]. Roč. 52, čís. 4, s. 583–589. Dostupné online. DOI 10.1016/j.immuni.2020.03.007. PMID 32259480. (anglicky) 
  • LUKE, Thomas; WU, Hua; ZHAO, Jincun; CHANNAPPANAVAR, Rudragouda; COLEMAN, Christopher M.; JIAO, Jin-An; MATSUSHITA, Hiroaki. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. S. 326ra21–326ra21. Science Translational Medicine [online]. 2016-02-17 [cit. 2020-10-28]. Roč. 8, čís. 326, s. 326ra21–326ra21. Dostupné online. DOI 10.1126/scitranslmed.aaf1061. PMID 26888429. (anglicky) 
  • BRAY, Natasha. Cattle engineered to produce human antibodies against coronavirus. S. 234. Nature Reviews Drug Discovery [online]. 2016-04 [cit. 2020-10-28]. Roč. 15, čís. 4, s. 234. Dostupné online. DOI 10.1038/nrd.2016.59. PMID 27032835. (anglicky) 
  • FRANCO-PAREDES, Carlos. Transmissibility of SARS-CoV-2 among fully vaccinated individuals. The Lancet Infectious Diseases. 2022-01-01, roč. 22, čís. 1, s. 16. PMID: 34953540. Dostupné online [cit. 2023-03-30]. ISSN 1473-3099. DOI 10.1016/S1473-3099(21)00768-4. PMID 34953540. (anglicky) 
  • SINGANAYAGAM, Anika; HAKKI, Seran; DUNNING, Jake. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases. 2022-02, roč. 22, čís. 2, s. 183–195. Dostupné online [cit. 2023-03-31]. DOI 10.1016/S1473-3099(21)00648-4. PMID 34756186. (anglicky) 
  • WILDER-SMITH, Annelies. What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?. The Lancet Infectious Diseases. 2022-02, roč. 22, čís. 2, s. 152–153. Dostupné online [cit. 2023-03-31]. DOI 10.1016/S1473-3099(21)00690-3. PMID 34756187. (anglicky) 
  • BERGWERK, Moriah; GONEN, Tal; LUSTIG, Yaniv. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. The New England Journal of Medicine. 2021-10-14, roč. 385, čís. 16, s. 1474–1484. PMID: 34320281 PMCID: PMC8362591. Dostupné online [cit. 2023-03-31]. ISSN 1533-4406. DOI 10.1056/NEJMoa2109072. PMID 34320281. (anglicky) 
  • REGEV-YOCHAY, Gili; GONEN, Tal; GILBOA, Mayan. Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron. New England Journal of Medicine. 2022-04-07, roč. 386, čís. 14, s. 1377–1380. Dostupné online [cit. 2023-03-31]. ISSN 0028-4793. DOI 10.1056/nejmc2202542. PMID 35297591. (anglicky) 
  • HAGAN, Liesl M.; MCCORMICK, David W.; LEE, Christine. Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021. MMWR. Morbidity and mortality weekly report. 2021-09-24, roč. 70, čís. 38, s. 1349–1354. PMID: 34555009 PMCID: PMC8459894. Dostupné online [cit. 2023-03-31]. ISSN 1545-861X. DOI 10.15585/mmwr.mm7038e3. PMID 34555009. (anglicky) 
  • ACHARYA, Charlotte B; SCHROM, John; MITCHELL, Anthea M. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant. Open Forum Infectious Diseases. 2022-05-01, roč. 9, čís. 5, s. ofac135. Dostupné online [cit. 2023-03-31]. ISSN 2328-8957. DOI 10.1093/ofid/ofac135. PMID 35479304. (anglicky) 
  • BARDOSH, Kevin; KRUG, Allison; JAMROZIK, Euzebiusz. COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities. Journal of Medical Ethics. 2022-12-05. PMID: 36600579. Dostupné online [cit. 2023-03-31]. ISSN 0306-6800. DOI 10.1136/jme-2022-108449. PMID 36600579. (anglicky) 
  • LAM, Leo L.; NICHOLS, Taylor. Ethics of college vaccine mandates, using reasonable comparisons. Journal of Medical Ethics. 2023-03-30. PMID: 36997309. Dostupné online [cit. 2023-04-23]. ISSN 0306-6800. DOI 10.1136/jme-2022-108852. PMID 36997309. (anglicky) 
  • ANDREWS, Nick; STOWE, Julia; KIRSEBOM, Freja. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. The New England Journal of Medicine. 2022-03-02, s. NEJMoa2119451. PMID: 35249272 PMCID: PMC8908811. Dostupné online [cit. 2023-04-02]. ISSN 0028-4793. DOI 10.1056/NEJMoa2119451. PMID 35249272. (anglicky) 
  • IRRGANG, Pascal; GERLING, Juliane; KOCHER, Katharina. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science Immunology. 2023-01-27, roč. 8, čís. 79, s. eade2798. Dostupné online [cit. 2023-04-20]. ISSN 2470-9468. DOI 10.1126/sciimmunol.ade2798. PMID 36548397. (anglicky) 
  • OLIVER, Sara E.; GARGANO, Julia W.; MARIN, Mona; WALLACE, Megan; CURRAN, Kathryn G.; CHAMBERLAND, Mary; MCCLUNG, Nancy. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020. MMWR. Morbidity and Mortality Weekly Report. December 2020, s. 1653–1656. Dostupné online. DOI 10.15585/mmwr.mm695152e1. PMID 33382675. 
  • Burki TK. The Russian vaccine for COVID-19. The Lancet. Respiratory Medicine. November 2020, s. e85–e86. Dostupné online. DOI 10.1016/S2213-2600(20)30402-1. PMID 32896274. 
  • DAG BERILD, Jacob; BERGSTAD LARSEN, Vilde; MYRUP THIESSON, Emilia. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries. JAMA Network Open. 2022-06-14, roč. 5, čís. 6, s. e2217375. Dostupné online [cit. 2023-04-20]. ISSN 2574-3805. DOI 10.1001/jamanetworkopen.2022.17375. PMID 35699955. (anglicky) 
  • KING, Jeff; FERRAZ, Octávio Luiz Motta; JONES, Andrew. Mandatory COVID-19 vaccination and human rights. The Lancet. 2022-01-15, roč. 399, čís. 10321, s. 220–222. PMID: 34953527. Dostupné online [cit. 2023-03-30]. ISSN 0140-6736. DOI 10.1016/S0140-6736(21)02873-7. PMID 34953527. (anglicky) 
  • CHENG, F. K. Debate on mandatory COVID-19 vaccination. Ethics, Medicine, and Public Health. 2022-04, roč. 21, s. 100761. PMID: 35097181. Dostupné online [cit. 2023-03-30]. DOI 10.1016/j.jemep.2022.100761. PMID 35097181. (anglicky) 
  • FRAIMAN, Joseph; ERVITI, Juan; JONES, Mark. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022-09-22, roč. 40, čís. 40, s. 5798–5805. PMID: 36055877 PMCID: PMC9428332. Dostupné online [cit. 2023-03-30]. ISSN 1873-2518. DOI 10.1016/j.vaccine.2022.08.036. PMID 36055877. (anglicky) 

pubmed.ncbi.nlm.nih.gov

  • BERGWERK, Moriah; GONEN, Tal; LUSTIG, Yaniv. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. The New England Journal of Medicine. 2021-10-14, roč. 385, čís. 16, s. 1474–1484. PMID: 34320281 PMCID: PMC8362591. Dostupné online [cit. 2023-03-31]. ISSN 1533-4406. DOI 10.1056/NEJMoa2109072. PMID 34320281. (anglicky) 
  • HAGAN, Liesl M.; MCCORMICK, David W.; LEE, Christine. Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021. MMWR. Morbidity and mortality weekly report. 2021-09-24, roč. 70, čís. 38, s. 1349–1354. PMID: 34555009 PMCID: PMC8459894. Dostupné online [cit. 2023-03-31]. ISSN 1545-861X. DOI 10.15585/mmwr.mm7038e3. PMID 34555009. (anglicky) 
  • FRAIMAN, Joseph; ERVITI, Juan; JONES, Mark. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022-09-22, roč. 40, čís. 40, s. 5798–5805. PMID: 36055877 PMCID: PMC9428332. Dostupné online [cit. 2023-03-30]. ISSN 1873-2518. DOI 10.1016/j.vaccine.2022.08.036. PMID 36055877. (anglicky) 

nih.gov

  • NIH clinical trial of investigational vaccine for COVID-19 begins [online]. National Institutes of Health, 2020-03-16 [cit. 2020-10-28]. Dostupné online. (anglicky) 

nikkei.com

asia.nikkei.com

  • Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use. Nikkei Asia. 14 February 2021. Dostupné online [cit. 14 February 2021]. 
  • IWAMOTO, Kentaro. Deaths jumped 8.9% in Japan in 2022 to almost double birth total. Nikkei Asia [online]. asia.nikkei.com, 2023-02-28 [cit. 2023-04-24]. Dostupné online. (anglicky) 

nova.cz

tn.nova.cz

  • POSPÍŠILOVÁ, Klára. Ve skladech leží ladem statisíce dávek vakcín. PŘEHLED po krajích. TV Nova [online]. 2021-03-10 [cit. 2021-03-11]. Dostupné online. 
  • DRGÁČ, Zdeněk. Lékaře v Německu zahltili pacienti. Stěžují si na potíže po vakcíně na covid | TN.cz. tn.nova.cz [online]. The Associated Press (AP), 2023-04-04 [cit. 2023-04-07]. Dostupné online. 

novinky.cz

npr.org

  • Moderna's Vaccine Candidate Heads To Testing In Up To 30,000 People : Coronavirus Live Updates : NPR. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 

nytimes.com

  • SANGER, David E.; KIRKPATRICK, David D.; ZIMMER, Carl; THOMAS, Katie; WEE, Sui-Lee. With Pressure Growing, Global Race for a Vaccine Intensifies. The New York Times. 2020-05-02. Dostupné v archivu pořízeném z originálu dne 11 May 2020. ISSN 0362-4331. 
  • WEE, Sui-Lee. China's coronavirus vaccine drive empowers a troubled industry. The New York Times. 4 May 2020. Dostupné v archivu pořízeném z originálu dne 4 May 2020. ISSN 0362-4331. 
  • CORUM, Jonathan; ZIMMER, Carl. How Gamaleya’s Vaccine Works. The New York Times. 2021-01-07. Dostupné online [cit. 2021-11-22]. ISSN 0362-4331. (anglicky) 
  • STOLBERG, Sheryl Gay. Covid-19 Live Updates: Scientists Are Studying Whether Moderna Supply Can Be Doubled By Cutting Doses in Half. The New York Times [online]. 2021-01-05 [cit. 2021-01-05]. Dostupné online. ISSN 0362-4331. (anglicky) 
  • ZIMMER, Carl; CORUM, Jonathan; WEE, Sui-Lee. Coronavirus Vaccine Tracker. The New York Times. 10 June 2020. Dostupné online [cit. 12 December 2020]. ISSN 0362-4331. 
  • SCHMALL, Emily; YASIR, Sameer. India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other. The New York Times. 3 January 2021. Dostupné online [cit. 3 January 2021]. 
  • WEE, Sui-Lee. Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl. The New York Times. 9 December 2020. Dostupné online [cit. 12 December 2020]. 
  • SCHMALL, Emily; YASIR, Sameer. India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other. The New York Times. 2021-01-03. Dostupné online [cit. 2021-01-08]. ISSN 0362-4331. (anglicky) 

oup.com

academic.oup.com

  • NIKOLAIDIS, Marios; MARKOULATOS, Panayotis; VAN DE PEER, Yves. The Neighborhood of the Spike Gene Is a Hotspot for Modular Intertypic Homologous and Nonhomologous Recombination in Coronavirus Genomes. Molecular Biology and Evolution. 2021-10-12, s. msab292. Dostupné online [cit. 2021-11-22]. ISSN 0737-4038. DOI 10.1093/molbev/msab292. PMID 34638137. (anglicky) 
  • ACHARYA, Charlotte B; SCHROM, John; MITCHELL, Anthea M. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant. Open Forum Infectious Diseases. 2022-05-01, roč. 9, čís. 5, s. ofac135. Dostupné online [cit. 2023-03-31]. ISSN 2328-8957. DOI 10.1093/ofid/ofac135. PMID 35479304. (anglicky) 

ox.ac.uk

paho.org

  • Nurse administers first shot of AstraZeneca ( ChAdOx1 nCoV-19, ) vaccine to Brinnet Bernarai at Georgetown Public Hospital Corporation - PAHO/WHO | Pan American Health Organization [online]. [cit. 2021-02-19]. Dostupné online. 

pattayamail.com

  • Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca. pattayamail.com [online]. 2021-01-23 [cit. 2021-02-25]. Dostupné online. (anglicky) 

pfizer.com

  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY® [online]. Pfizer a BioNTech, 2021-02-17 [cit. 2021-02-17]. Dostupné online. 
  • PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED SUCCESS IN FIRST INTERIM ANALYSIS FROM PHASE 3 STUDY [online]. Pfizer, 2020-11-09 [cit. 2020-11-20]. Dostupné online. (anglicky) 

pharmiweb.com

  • PharmiWeb.com: Sputnik V authorized in Iraq, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.

phys.org

  • These fridge-free COVID-19 vaccines are grown in plants and bacteria. phys.org [online]. 2021-09-07 [cit. 2022-01-10]. Dostupné online. (anglicky) 

politico.com

praha.eu

ockovani.praha.eu

precisionvaccinations.com

  • CARLSON, Robert. European Agency Confirms COVID-19 Vaccine Fatalities. www.precisionvaccinations.com [online]. Precision Vaccinations, 2021-07-14 [cit. 2023-04-11]. Dostupné v archivu pořízeném z originálu dne 2023-03-27. (anglicky) 

rdif.ru

  • Palestine has become the first country in the Middle East to register Sputnik V vaccine. RFID. 11 January 2021. Dostupné online. 

reflex.cz

  • PEČINKA, Bohumil. Nad očkovací strategií ministerstva jsem se zhrozil, říká jihočeský hejtman Martin Kuba. [[Reflex (časopis)|Reflex]] [online]. 2021-01-21 [cit. 2021-01-22]. Dostupné online. 

reuters.com

reuters.com

  • STEENHUYSEN, Julie; EISLER, Peter; MARTELL, Allison; NEBEHAY, Stephanie. Special Report: Countries, companies risk billions in race for coronavirus vaccine. Reuters. 2020-04-27. Dostupné v archivu pořízeném z originálu dne 15 May 2020. 
  • Russia approves its third COVID-19 vaccine, CoviVac. Reuters. 2021-02-20. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • REUTERS. Kazakhstan rolls out its own COVID-19 vaccine. Reuters. 2021-04-27. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • S.Korea's Genexine begins human trial of coronavirus vaccine. Reuters. 2020-06-19. Dostupné online [cit. 2021-11-22]. (anglicky) 
  • EU drug regulator expresses doubt on need for fourth booster dose. Reuters. 2022-01-11. Dostupné online [cit. 2023-04-08]. (anglicky) 
  • Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week [online]. Reuters [cit. 2020-12-24]. Dostupné online. 
  • Oman issues licence to import Pfizer BioNTech Covid vaccine – TV. www.reuters.com. Reuters, 15 December 2020. Dostupné online [cit. 16 December 2020]. 
  • Suriname begins coronavirus vaccination campaign with donated doses. www.reuters.com. Reuters, 23 February 2021. Dostupné online [cit. 28 February 2021]. 
  • Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine [online]. 3 February 2021 [cit. 2021-02-03]. Dostupné online. 
  • SEDIQI, Abdul Qadir. First doses of COVID-19 vaccine arrive in Afghanistan from India. Reuters. 2021-02-07. Dostupné online [cit. 2021-02-24]. (anglicky) 
  • Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine [online]. Reuters, 30 December 2020 [cit. 2020-12-30]. Dostupné online. 
  • MCGEEVER, Jamie; FONSECA, Pedro. Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin. Reuters. 17 January 2021. Dostupné online [cit. 17 January 2021]. 
  • Ecuador approves use of AstraZeneca vaccine for COVID-19. Reuters [online]. 2021-01-24 [cit. 2021-02-25]. Dostupné online. (anglicky) 
  • STAFF, Reuters. Philippine regulator approves emergency use of AstraZeneca vaccine. Reuters. 28 January 2021. Dostupné online [cit. 28 January 2021]. 
  • STAFF, Reuters. Nepal approves AstraZeneca COVID vaccine for emergency use - government statement. Reuters. 15 January 2021. Dostupné online. (anglicky) 
  • STAFF, Reuters. Pakistan approves AstraZeneca COVID-19 vaccine for emergency use. www.reuters.com. 16 January 2021. Dostupné online. (anglicky) 
  • El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine. www.reuters.com. Reuters, 30 December 2020. Dostupné online. 
  • Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF. www.reuters.com. Reuters, 1 February 2021. Dostupné online [cit. 1 February 2021]. 
  • Bahrain authorises Sputnik V COVID-19 vaccine for emergency use - Bahrain TV. Reuters [online]. 2021-02-10 [cit. 2021-02-25]. Dostupné online. (anglicky) 
  • Belarus registers Sputnik V vaccine, in first outside Russia - RDIF. www.reuters.com. Reuters, 21 December 2020. Dostupné online [cit. 22 December 2020]. 
  • Montenegro and St. Vincent approve Russia's Sputnik V vaccine - RDIF. www.reuters.com. Reuters, 12 February 2021. Dostupné online. 
  • Guatemala to receive Russia's Sputnik vaccine in coming weeks. www.reuters.com. Reuters, 24 February 2021. Dostupné online. 
  • Iran approves Russian coronavirus vaccine Sputnik V. www.reuters.com. Reuters, 26 January 2021. Dostupné online. 
  • Paraguay approves Russia's Sputnik V vaccine: RDIF. www.reuters.com. Reuters, 15 January 2021. Dostupné online [cit. 15 January 2021]. 
  • Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V. www.reuters.com. Reuters, 29 December 2020. Dostupné online. (španělsky) 
  • Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine. Reuters. 3 March 2021. Dostupné online. 
  • Sinovac's COVID-19 vaccine induces quick immune response - study. Reuters [online]. 2020-11-17. Dostupné online. 
  • Philippines approves Sinovac's COVID-19 vaccine for emergency use. Reuters. 22 February 2021. Dostupné online. 
  • LIU, Roxanne. China approves Sinovac Biotech COVID-19 vaccine for general public use [online]. 6 February 2021 [cit. 2021-02-07]. Dostupné online. 
  • BARRERA, Adriana. Mexico approves China's CanSino and Sinovac COVID-19 vaccines [online]. 11 February 2021 [cit. 2021-02-11]. Dostupné online. (anglicky) 
  • THEPGUMPANAT, Panarat. Thailand allows emergency use of Sinovac's COVID-19 vaccine [online]. 22 February 2021 [cit. 2021-02-23]. Dostupné online. (anglicky) 
  • BIANNCHI, Walter. Argentina approves Sinopharm COVID-19 vaccine for emergency use [online]. Reuters, 21 February 2021 [cit. 2021-02-23]. Dostupné online. (anglicky) 
  • SHAHZAD, Asif. Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use. Reuters [online]. 2021-01-19 [cit. 2021-02-25]. Dostupné online. (anglicky) 
  • Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine - government sources [online]. 27 January 2021. Dostupné online. 
  • STAFF, Reuters. CanSino's COVID-19 vaccine candidate approved for military use in China. Reuters. 2020-06-29. Dostupné online [cit. 2021-01-09]. (anglicky) 
  • SHAHZAD, Asif. Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use. www.reuters.com. Reuters, 12 February 2021. Dostupné online [cit. 12 February 2021]. 
  • Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use. Reuters. 25 February 2021. Dostupné online [cit. 25 February 2021]. 
  • Fauci urges Americans to get any of the three COVID-19 vaccines available. Reuters [online]. 2021-02-28 [cit. 2021-02-28]. Dostupné online. (anglicky) 
  • IVANOVA, Polina. Russia approves its third COVID-19 vaccine, CoviVac. Reuters. 2021-02-20. Dostupné online [cit. 2021-02-24]. (anglicky) 
  • Reuters Staff. WHO does not envisage COVID-19 vaccines being made mandatory. Reuters. 2020-12-07. Dostupné online [cit. 2023-03-30]. (anglicky) 

in.reuters.com

  • Colombia regulator approves Pfizer-BioNTech vaccine for emergency use. Reuters. 6 January 2021. Dostupné online [cit. 6 January 2021]. 

rferl.org

  • North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts [online]. [cit. 2021-02-19]. Dostupné online. 
  • Serbia Becomes First European Nation To Use China's Sinopharm Vaccine. rferl.org [online]. 2021-01-20 [cit. 2021-02-25]. Dostupné online. (anglicky) 

rospotrebnadzor.ru

  • О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора «ЭпиВакКорона» [online]. 14 October 2020. Dostupné online. (rusky) 

royanews.tv

en.royanews.tv

  • Syria authorizes use of Sputnik-V. en.royanews.tv. Roya, 22 February 2021. Dostupné online. 
  • First batch of Chinese Sinopharm vaccine arrives in Jordan [online]. Roya News [cit. 2021-01-09]. Dostupné online. 

rozhlas.cz

radiozurnal.rozhlas.cz

  • SKALICKÝ, Matěj. Vakcína společnosti AstraZeneca chrání i seniory, prokázala studie. Změní Česko očkovací strategii?. Radiožurnál [online]. Český rozhlas, 2021-03-04 [cit. 2021-03-11]. Dostupné online. 
  • CHUM, Jiří. Výhody vakcíny AstraZeneca převažují nad riziky, tvrdí experti. Očkování v Česku pokračuje. Radiožurnál [online]. Český rozhlas, 2021-04-08 [cit. 2023-03-30]. Dostupné online. 

dvojka.rozhlas.cz

  • Imunolog Hořejší: Bývali jsme téměř velmocí ve vývoji vakcín. Měli bychom v tom pokračovat. Dvojka [online]. Český rozhlas, 2021-03-09 [cit. 2021-03-09]. Dostupné online. 

sanofi.com

  • Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly [online]. Sanofi, 2020-12-11 [cit. 2020-12-28]. Dostupné online. (anglicky) 

saudigazette.com.sa

  • Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India. saudigazette.com.sa [online]. 2021-01-25 [cit. 2021-02-25]. Dostupné online. (anglicky) 

science.org

sciencedirect.com

  • GAO, Feng-Xia; WU, Rui-Xin; SHEN, Mei-Ying. Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice. iScience. 2022-12-22, roč. 25, čís. 12, s. 105479. Dostupné online [cit. 2023-04-08]. ISSN 2589-0042. DOI 10.1016/j.isci.2022.105479. (anglicky) 

sciencemag.org

stm.sciencemag.org

  • LUKE, Thomas; WU, Hua; ZHAO, Jincun; CHANNAPPANAVAR, Rudragouda; COLEMAN, Christopher M.; JIAO, Jin-An; MATSUSHITA, Hiroaki. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. S. 326ra21–326ra21. Science Translational Medicine [online]. 2016-02-17 [cit. 2020-10-28]. Roč. 8, čís. 326, s. 326ra21–326ra21. Dostupné online. DOI 10.1126/scitranslmed.aaf1061. PMID 26888429. (anglicky) 

scientificamerican.com

  • SCHMIDT, Charles. Genetic Engineering Could Make a COVID-19 Vaccine in Months Rather Than Years. Scientific American. 1 June 2020. Dostupné v archivu pořízeném z originálu dne 11 October 2020. 

scmp.com

  • JEONG-HO, Lee; ZHENG, William; ZHOU, Laura. Chinese scientists race to develop vaccine as coronavirus death toll jumps. South China Morning Post. 26 January 2020. Dostupné v archivu pořízeném z originálu dne 26 January 2020. 
  • CHEN, Stephen. Low antibody levels raise questions about coronavirus reinfection risk. South China Morning Post [online]. 2020-04-07 [cit. 2020-10-28]. Dostupné online. (anglicky) 

seenews.com

  • Albania to start COVID-19 immunisation with Pfizer vaccine in Jan – report [online]. Dostupné online. 

semanticscholar.org

api.semanticscholar.org

seznamzpravy.cz

shinyapps.io

vac-lshtm.shinyapps.io

  • COVID-19 vaccine development pipeline (Refresh URL to update) [online]. Vaccine Centre, London School of Hygiene and Tropical Medicine, 16 December 2020 [cit. 2020-12-18]. Dostupné online. 
  • COVID-19 vaccine tracker. vac-lshtm.shinyapps.io [online]. [cit. 2021-11-22]. Dostupné online. 

sputnikvaccine.com

  • The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets [online]. Sputnikvaccine.com. Dostupné online. 
  • About Vaccine: General information. sputnikvaccine.com. Dostupné online [cit. 14 January 2021]. 
  • Argentina has registered the Sputnik V vaccine based on Russian clinical trial data. sputnikvaccine.com. Dostupné online [cit. 1 January 2021]. 
  • Sputnik V authorised in Gabon. sputnikvaccine.com. Dostupné online [cit. 17 February 2021]. 
  • Sputnik V vaccine authorized in Tunisia. sputnikvaccine.com. Dostupné online [cit. 30 January 2021]. 
  • Sputnik V registered in Kyrgyzstan. sputnikvaccine.com. 23 February 2021. Dostupné online. 

srbija.gov.rs

  • First shipment of Pfizer-BioNTech vaccine arrives in Serbia. Serbian government website. 22 December 2020. Dostupné online [cit. 26 December 2020]. 

ssrn.com

papers.ssrn.com

  • VOYSEY, Merryn; COSTA CLEMENS, Sue Ann; MADHI, Shabir A.; WECKX, Lily Yin; FOLEGATTI, Pedro M.; ALEY, Parvinder K.; ANGUS, Brian John. Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine. papers.ssrn.com [online]. Social Science Research Network, 2021-02-01 [cit. 2021-02-25]. Dostupné online. (anglicky) 

statehouse.gov.sc

  • President Ramkalawan and First Lady receives second dose SinoPharm Vaccine [online]. [cit. 2021-02-05]. Dostupné online. (anglicky) 

statista.com

  • Japan: number of deaths by prefecture. Statista [online]. [cit. 2023-04-24]. Dostupné online. (anglicky) 

statnews.com

  • SANTIAGO, Jahleah. A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines [online]. 19 December 2020 [cit. 2020-12-24]. Dostupné online. 
  • BRANSWELL, Helen. Sanofi and GSK move Covid-19 vaccine into human trials. statnews.com [online]. 2020-09-03 [cit. 2020-12-28]. Dostupné online. (anglicky) 

straitstimes.com

  • Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use [online]. 17 December 2020 [cit. 2020-12-17]. Dostupné online. 
  • SOERIAATMADJA, Wahyudi. Indonesia grants emergency use approval to Sinovac’s vaccine, local trials show 65% efficacy. The Straits Times. 2021-01-11. Dostupné online [cit. 2021-01-11]. 

sukl.cz

sukl.cz

nezadouciucinky.sukl.cz

  • Nežádoucí účinky. nezadouciucinky.sukl.cz [online]. Státní ústav pro kontrolu léčiv [cit. 2024-09-09]. Dostupné online. 

swissmedic.ch

swissmedicinfo.ch

  • Comirnaty Product information [online]. [cit. 2021-01-31]. Dostupné online. (DE) 

tandfonline.com

tass.com

  • Myanmar registers Russia’s Sputnik V COVID-19 vaccine. TASS [online]. 2020-02-06 [cit. 2021-02-25]. Dostupné online. (anglicky) 
  • Three more countries register Russian Sputnik V vaccine. TASS. 11 March 2021. Dostupné online. 

tdh.gov.tm

  • Turkmenistan registers vaccines for the prevention of infectious diseases. Turkmenistan Today. 29 January 2021. Dostupné online. (anglicky) 

tempo.co

en.tempo.co

  • BPOM Grants Emergency Use Authorization for Sinovac Vaccine. Tempo. 2021-01-11. Dostupné online [cit. 2021-01-11]. 

texastribune.org

  • BROOKS HARPER, Karen; AGUILAR, Julián. As COVID-19 vaccine arrives in Texas' hard-hit border areas, experts warn vaccinated people could still spread virus. The Texas Tribune [online]. 2020-12-16 [cit. 2020-12-28]. Dostupné online. (anglicky) 

tga.gov.au

  • Comirnaty [online]. 25 January 2021 [cit. 2021-01-25]. Dostupné online. 
  • TGA provisionally approves AstraZeneca's COVID-19 vaccine [online]. 16 February 2021 [cit. 2021-02-16]. Dostupné online. 

theconversation.com

  • GRENFELL, Rob; DREW, Trevor. Here's why the WHO says a coronavirus vaccine is 18 months away [online]. 14 February 2020 [cit. 2020-11-11]. Dostupné online. 
  • GIUBILINI, Alberto; JAIN, Vageesh. Should COVID-19 vaccines be mandatory? Two experts discuss. The Conversation [online]. The Conversation Media Group, 2020-11-25 [cit. 2023-03-30]. Dostupné online. (anglicky) 

thedailystar.net

  • Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use [online]. [cit. 2021-01-06]. Dostupné online. (anglicky) 

thegatewaypundit.com

  • HOFT, Jim. Japanese Officials Urge Government to Tell the Truth About Excess Deaths Following Vaccine Mandates - Reporting Shows 210,000 Excess Deaths, the Highest Number Since World War II (VIDEO). www.thegatewaypundit.com [online]. The Gateway Pundit, 2023-03-16 [cit. 2023-04-24]. Dostupné online. (anglicky) 

theglobeandmail.com

  • G20 launches initiative for health tools needed to combat the coronavirus. www.theglobeandmail.com. 25 April 2020. Dostupné online. 
  • WU, Huizhong. China prepares large-scale rollout of domestically-produced coronavirus vaccines. The Globe and Mail. 6 December 2020. Dostupné online [cit. 7 December 2020]. 

theguardian.com

  • Beaumont P. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 18 November 2020. Dostupné online [cit. 26 December 2020]. ISSN 0261-3077. 
  • Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows. The Guardian [online]. 2020-11-18. Dostupné online. 

thehindu.com

  • Sri Lanka approves Russia's Sputnik V vaccine. The Hindu. 4 March 2021. Dostupné online. 
  • Coronavirus | Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine. The Hindu. 2021-01-03. Dostupné online [cit. 2021-01-29]. ISSN 0971-751X. (anglicky) 

thejakartapost.com

  • Mexico, Germany warm to Russia's Sputnik V virus vaccine. The Jakarta Post. 3 February 2021. Dostupné online. 

thelancet.com

  • LANE, Richard. Sarah Gilbert: carving a path towards a COVID-19 vaccine. S. 1247. The Lancet [online]. 2020-04-18 [cit. 2020-10-28]. Roč. 395, čís. 10232, s. 1247. Dostupné online. DOI 10.1016/S0140-6736(20)30796-0. (anglicky) 
  • BALAKRISHNAN, Vijay Shankar. The arrival of Sputnik V. S. 1128. The Lancet Infectious Diseases [online]. 2020-10-01 [cit. 2021-01-03]. Roč. 20, čís. 10, s. 1128. Dostupné online. DOI 10.1016/S1473-3099(20)30709-X. (anglicky) 
  • DEMONBREUN, Alexis R.; SANCILIO, Amelia; VELEZ, Matt P.; RYAN, Daniel T.; SABER, Rana; VAUGHT, Lauren A.; REISER, Nina L. Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.. S. 101018. EClinicalMedicine [online]. 2021-08. Roč. 38, s. 101018. Dostupné online. DOI 10.1016/j.eclinm.2021.101018. (anglicky) 
  • FRANCO-PAREDES, Carlos. Transmissibility of SARS-CoV-2 among fully vaccinated individuals. The Lancet Infectious Diseases. 2022-01-01, roč. 22, čís. 1, s. 16. PMID: 34953540. Dostupné online [cit. 2023-03-30]. ISSN 1473-3099. DOI 10.1016/S1473-3099(21)00768-4. PMID 34953540. (anglicky) 
  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet [online]. [cit. 2020-12-09]. Dostupné online. 
  • LOGUNOV, Denis Y; DOLZHIKOVA, Inna V; SHCHEBLYAKOV, Dmitry V; TUKHVATULIN, Amir I; ZUBKOVA, Olga V; DZHARULLAEVA, Alina S; KOVYRSHINA, Anna V. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. S. 671–681. The Lancet [online]. 2021-02. Roč. 397, čís. 10275, s. 671–681. Dostupné online. DOI 10.1016/S0140-6736(21)00234-8. (anglicky) 
  • Burki TK. The Russian vaccine for COVID-19. The Lancet. Respiratory Medicine. November 2020, s. e85–e86. Dostupné online. DOI 10.1016/S2213-2600(20)30402-1. PMID 32896274. 
  • ZHU, Feng-Cai; GUAN, Xu-Hua; LI, Yu-Hua; HUANG, Jian-Ying; JIANG, Tao; HOU, Li-Hua; LI, Jing-Xin. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. S. 479–488. The Lancet [online]. 2020-08 [cit. 2021-02-25]. Roč. 396, čís. 10249, s. 479–488. Dostupné online. DOI 10.1016/S0140-6736(20)31605-6. (anglicky) 
  • KING, Jeff; FERRAZ, Octávio Luiz Motta; JONES, Andrew. Mandatory COVID-19 vaccination and human rights. The Lancet. 2022-01-15, roč. 399, čís. 10321, s. 220–222. PMID: 34953527. Dostupné online [cit. 2023-03-30]. ISSN 0140-6736. DOI 10.1016/S0140-6736(21)02873-7. PMID 34953527. (anglicky) 

themoscowtimes.com

  • Hungarian drug regulator approves Sputnik V vaccine: website. www.themoscowtimes.com. The Moscow Times, 7 February 2021. Dostupné online. 

thenationalnews.com

  • Coronavirus: UAE authorises emergency use of vaccine for frontline workers [online]. [cit. 2020-11-24]. Dostupné online. 

thenigerianvoice.com

  • Understanding What Russia's Sputnik V Could Mean for Africa. The Nigerian Voice. 11 March 2021. Dostupné online. 

thepharmaletter.com

  • Russia's EpiVacCorona vaccine post-registration trials started [online]. The Pharma Letter, 18 November 2020. Dostupné online. 

thestar.com

  • BLANCHFIELD, Mike. Global philanthropists, experts call for COVID-19 vaccine distribution plan. Toronto Star. 30 April 2020. Dostupné v archivu pořízeném z originálu dne 7 May 2020. 
  • MUTSAKA, Farai. Zimbabwe starts administering China's Sinopharm vaccines [online]. The Star, 18 February 2021 [cit. 2021-02-20]. Dostupné online. (anglicky) 

thestar.com.my

  • Laos declares Covid-19 vaccinations safe, more to be inoculated next week. thestar.com.my [online]. 2021-01-06 [cit. 2021-02-25]. Dostupné online. (anglicky) 
  • Laos declares Covid-19 vaccinations safe, more to be inoculated next week | The Star [online]. [cit. 2021-02-19]. Dostupné online. 

thesun.co.uk

  • WILLIAMS, Terri-Ann. Two doses of Pfizer's vaccine prevent '99.96% of Covid cases', study suggests. The Sun [online]. 2021-01-29 [cit. 2022-01-10]. Dostupné online. (anglicky) 

ticotimes.net

  • Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine [online]. 16 December 2020 [cit. 2020-12-16]. Dostupné online. 

trackvaccines.org

covid19.trackvaccines.org

  • Liechtenstein – COVID19 Vaccine Tracker [online]. [cit. 2021-02-19]. Dostupné online. 

trust.org

news.trust.org

  • Ghana approves Russia's Sputnik V vaccine for emergency use - RDIF. news.trust.org. Reuters, 20 February 2021. Dostupné online. 
  • Lebanon authorises emergency use of Russia's Sputnik V vaccine. news.trust.org. Reuters, 5 February 2021. Dostupné online. 

twitter.com

un.org

news.un.org

  • Leaders pledge ‘quantum leap’ towards fully funding COVID-19 vaccines and treatments [online]. 2020-09-10 [cit. 2020-09-11]. Dostupné online. (anglicky) 

unionesarda.it

  • San Marino buys the Sputnik vaccine: "First doses already in the next few days". Unioneonline. 20 February 2021. Dostupné online. 

uol.com.br

noticias.uol.com.br

  • Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19 [online]. [cit. 2021-01-06]. Dostupné online. (portugalsky) 

uq.edu.au

  • UQ vaccine scientists report positive results from pre-clinical testing. UQ News [online]. University of Queensland, 2020-08-26 [cit. 2020-12-28]. Dostupné online. (anglicky) 

urdupoint.com

  • Mongolia Approves Russia's Sputnik V Coronavirus Vaccine - RDIF. www.urdupoint.com. Urdu Point, 9 February 2021. Dostupné online. 

vaccine-safety-training.org

  • MODULE 2 – Subunit vaccines - WHO Vaccine Safety Basics. vaccine-safety-training.org [online]. [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2021-03-20. 

valneva.com

vaticannews.va

  • {{{publisher}}}: In Vaticano parte il piano vaccinale anticovid, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.

vg.no

  • Vaksinekappløpet – siste nytt. vg [online]. [cit. 2021-03-20]. Dostupné online. 

vnexpress.net

e.vnexpress.net

  • VnExpress: Vietnam approves US, Russia Covid-19 vaccines for emergency use, tisková zpráva, [cit. 2021-03-20], Dostupné on-line.
  • Vietnam approves US, Russia Covid-19 vaccines for emergency use. e.vnexpress.net. VnExpress. Dostupné online [cit. 26 February 2021]. 

washingtonpost.com

web.archive.org

  • What is the ACT Accelerator? [online]. World Health Organization, 2020 [cit. 2020-08-29]. Dostupné v archivu pořízeném z originálu dne 25 September 2020. 
  • WAKE, Damon. EU spearheads $8 billion virus fundraiser [online]. Yahoo Finance, 2020-05-04 [cit. 2020-05-04]. Dostupné v archivu pořízeném z originálu dne 29 June 2020. 
  • GloPID: Novel coronavirus COVID-19 [online]. [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 2 May 2020. 
  • STEENHUYSEN, Julie; EISLER, Peter; MARTELL, Allison; NEBEHAY, Stephanie. Special Report: Countries, companies risk billions in race for coronavirus vaccine. Reuters. 2020-04-27. Dostupné v archivu pořízeném z originálu dne 15 May 2020. 
  • SANGER, David E.; KIRKPATRICK, David D.; ZIMMER, Carl; THOMAS, Katie; WEE, Sui-Lee. With Pressure Growing, Global Race for a Vaccine Intensifies. The New York Times. 2020-05-02. Dostupné v archivu pořízeném z originálu dne 11 May 2020. ISSN 0362-4331. 
  • HAMILTON, Isobel Asher. Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates and one could be ready in as little as 9 months. Business Insider. 2020-05-01. Dostupné v archivu pořízeném z originálu dne 16 May 2020. 
  • GATES, Bill. The vaccine race explained: What you need to know about the COVID-19 vaccine [online]. The Gates Notes, 30 April 2020 [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 14 May 2020. 
  • SARS (severe acute respiratory syndrome) [online]. National Health Service, 5 March 2020 [cit. 2020-01-31]. Dostupné v archivu pořízeném z originálu dne 9 March 2020. 
  • World Health Organization timeline – COVID-19 [online]. World Health Organization, 27 April 2020 [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 29 April 2020. 
  • Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine [online]. World Health Organization, 27 April 2020 [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 30 April 2020. 
  • SCHMIDT, Charles. Genetic Engineering Could Make a COVID-19 Vaccine in Months Rather Than Years. Scientific American. 1 June 2020. Dostupné v archivu pořízeném z originálu dne 11 October 2020. 
  • FOX, Chris; KELION, Leo. Russian spies 'target coronavirus vaccine'. BBC News. 16 July 2020. Dostupné v archivu pořízeném z originálu dne 11 October 2020. 
  • JEONG-HO, Lee; ZHENG, William; ZHOU, Laura. Chinese scientists race to develop vaccine as coronavirus death toll jumps. South China Morning Post. 26 January 2020. Dostupné v archivu pořízeném z originálu dne 26 January 2020. 
  • WEE, Sui-Lee. China's coronavirus vaccine drive empowers a troubled industry. The New York Times. 4 May 2020. Dostupné v archivu pořízeném z originálu dne 4 May 2020. ISSN 0362-4331. 
  • Public statement for collaboration on COVID-19 vaccine development [online]. World Health Organization, 13 April 2020 [cit. 2020-04-20]. Dostupné v archivu pořízeném z originálu dne 20 April 2020. 
  • Clinical Development Success Rates 2006–2015 [online]. BIO Industry Analysis, June 2016 [cit. 2020-03-23]. Dostupné v archivu pořízeném z originálu dne 12 September 2019. 
  • What you need to know about the COVID-19 vaccine | Bill Gates. web.archive.org [online]. 2020-05-14 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-05-14. 
  • Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Clinical Trials Register. web.archive.org [online]. 2020-04-22 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-04-22. 
  • A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Moderna's Vaccine Candidate Heads To Testing In Up To 30,000 People : Coronavirus Live Updates : NPR. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Investigating a Vaccine Against COVID-19 - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Clinical Trials Register. web.archive.org [online]. 2020-10-05 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-05. 
  • A Study of Ad26.COV2.S in Adults (COVID-19) - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-09-16 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-09-16. 
  • A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-09-26 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-09-26. 
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals - Full Text View - ClinicalTrials.gov. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  •  :: Welcome Indonesia Registry Center ::. web.archive.org [online]. 2020-10-11 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform. www.chictr.org.cn [online]. [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-10-11. 
  • MODULE 2 – Subunit vaccines - WHO Vaccine Safety Basics. vaccine-safety-training.org [online]. [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2021-03-20. 
  • MVC COVID-19 Vaccine Obtains Taiwan EUA Approval. www.medigenvac.com [online]. [cit. 2021-11-22]. Dostupné v archivu pořízeném dne 2021-10-09. 
  • Bacille Calmette-Guérin (BCG) vaccination and COVID-19. web.archive.org [online]. 2020-04-30 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-04-30. 
  • GATES, Bill. The first modern pandemic: The scientific advances we need to stop COVID-19 [online]. The Gates Notes, 23 April 2020 [cit. 2020-05-06]. Dostupné v archivu pořízeném z originálu dne 13 May 2020. 
  • BLANCHFIELD, Mike. Global philanthropists, experts call for COVID-19 vaccine distribution plan. Toronto Star. 30 April 2020. Dostupné v archivu pořízeném z originálu dne 7 May 2020. 
  • UQ-CSL V451 Vaccine [online]. precisionvaccinations.com, rev. 2020-12-15 [cit. 2020-12-28]. Dostupné v archivu pořízeném dne 2020-12-19. (anglicky) 
  • Norwegian authorization">Statens legemiddelverk: Koronavaksinen fra BioNTech og Pfizer (Comirnaty) får betinget godkjenning i Europa., tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line. Archivováno 8. 1. 2021 na Wayback Machine.
  • Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures | Moderna, Inc. [online]. [cit. 2021-01-07]. Dostupné v archivu pořízeném dne 2020-11-16. (anglicky) 
  • BAUBEKOVA, Akdana. Kazakhstan begins mass vaccination by Russian Sputnik V. neweurope.eu [online]. 2021-02-01 [cit. 2021-02-25]. Dostupné v archivu pořízeném z originálu dne 2021-02-09. (anglicky) 
  • Turkmenistan is the first in Central Asia to have registered "Sputnik V" vaccine. Orient. 18 January 2021. Dostupné v archivu pořízeném dne 2021-01-27. 
  • Russian vaccine "EpiVacCorona" was registered in Turkmenistan. EN24. 29 January 2021. Dostupné v archivu pořízeném dne 2021-03-19. 
  • An overview of vaccine contracts for Iceland. covid.is [online]. [cit. 2021-03-20]. Dostupné v archivu pořízeném z originálu dne 2021-02-23. 
  • https://valneva.com/research-development/covid-19-vla2001/ Archivováno 14. 1. 2021 na Wayback Machine. - COVID-19 – VLA2001
  • CARLSON, Robert. European Agency Confirms COVID-19 Vaccine Fatalities. www.precisionvaccinations.com [online]. Precision Vaccinations, 2021-07-14 [cit. 2023-04-11]. Dostupné v archivu pořízeném z originálu dne 2023-03-27. (anglicky) 
  • KOMENDA, M.; PANOŠKA, P.; BULHART, V., a kol. COVID‑19: Přehled aktuální situace v ČR. Onemocnění aktuálně [online]. Ministerstvo zdravotnictví ČR, vývoj: Ústav zdravotnických informací a statistiky ČR a Institut biostatistiky a analýz Lékařské fakulty Masarykovy univerzity, 2020 [cit. 2024-09-07]. Dostupné v archivu pořízeném z originálu dne 2020-11-30. ISSN 2694-9423. 

weforum.org

who.int

who.int

  • Access to COVID-19 Tools (ACT) Accelerator. www.who.int. WHO, 24 April 2020. Dostupné online. 
  • WHO Director-General's opening remarks at the launch of the Access to COVID-19 Tools Accelerator. www.who.int. WHO, 24 April 2020. Dostupné online. 
  • The ACT-Accelerator: frequently asked questions (FAQ) [online]. World Health Organization, 2020 [cit. 2020-12-16]. Dostupné online. 
  • What is the ACT Accelerator? [online]. World Health Organization, 2020 [cit. 2020-08-29]. Dostupné v archivu pořízeném z originálu dne 25 September 2020. 
  • Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least US$ 153 billion in 2020–21, and US$ 466 billion by 2025, in 10 major economies, according to new report by the Eurasia Group [online]. World Health Organization, 4 December 2020 [cit. 2020-12-11]. Dostupné online. 
  • World Health Organization timeline – COVID-19 [online]. World Health Organization, 27 April 2020 [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 29 April 2020. 
  • Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine [online]. World Health Organization, 27 April 2020 [cit. 2020-05-02]. Dostupné v archivu pořízeném z originálu dne 30 April 2020. 
  • Public statement for collaboration on COVID-19 vaccine development [online]. World Health Organization, 13 April 2020 [cit. 2020-04-20]. Dostupné v archivu pořízeném z originálu dne 20 April 2020. 
  • Bacille Calmette-Guérin (BCG) vaccination and COVID-19. web.archive.org [online]. 2020-04-30 [cit. 2021-11-22]. Dostupné v archivu pořízeném z originálu dne 2020-04-30. 

cdn.who.int

  • WHO Target Product Profiles for COVID-19 Vaccines, Version 3. who.int [online]. World Health Organisation, 2020-04-29 [cit. 2024-09-08]. Dostupné online. (anglicky) 
  • WHO Target Product Profiles for COVID-19 Vaccines, April 2022 1/6 WHO Target Product Profiles for COVID-19 Vaccines, Revised version. who.int [online]. World Health Organisation, 2022-04 [cit. 2024-09-08]. Dostupné online. (anglicky) 

wiley.com

onlinelibrary.wiley.com

winfried-stoecker.de

worldcat.org

wsoctv.com

  • Nicaragua approves Russian COVID-19 vaccine. www.wsoctv.com. wsoctv, 3 February 2021. Dostupné online. 

xinhuanet.com

  • Maldives starts training healthcare workers on COVID-19 vaccine distribution - Xinhua | English.news.cn [online]. [cit. 2021-02-19]. Dostupné online. 
  • Myanmar launches nationwide COVID-19 vaccination program. Xinhua News. 27 January 2021. Dostupné online. 
  • Honduras approves use of Sputnik V vaccine against COVID-19. www.xinhuanet.com. 25 February 2021. Dostupné online. 
  • Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister. xinhuanet.com [online]. 2021-01-03 [cit. 2021-02-25]. Dostupné online. (anglicky) 

yabiladi.com

en.yabiladi.com

  • BABAS, Latifa. Covid-19 : Morocco authorizes use of the Sinopharm vaccine. en.yabiladi.com [online]. 2021-01-22 [cit. 2021-02-25]. Dostupné online. (anglicky) 

yahoo.com

finance.yahoo.com

  • WAKE, Damon. EU spearheads $8 billion virus fundraiser [online]. Yahoo Finance, 2020-05-04 [cit. 2020-05-04]. Dostupné v archivu pořízeném z originálu dne 29 June 2020. 
  • Panama approves Pfizer's COVID-19 vaccine – health ministry [online]. Yahoo! Finance [cit. 2020-12-16]. Dostupné online. 

yna.co.kr

en.yna.co.kr

  • KIM, Han-joo. S. Korea approves AstraZeneca's COVID-19 vaccine for all adults. Yonhap News Agency. 2021-02-10. Dostupné online [cit. 2021-02-10]. (anglicky)